Marilyn A. Huestis - Publications

Affiliations: 
Toxicology University of Maryland School of Medicine, Baltimore, MD, United States 
Area:
Toxicology, Pharmacology, Biochemistry

392 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Karschner EL, Swortwood-Gates MJ, Huestis MA. Identifying and Quantifying Cannabinoids in Biological Matrices in the Medical and Legal Cannabis Era. Clinical Chemistry. 66: 888-914. PMID 32628766 DOI: 10.1093/clinchem/hvaa113  0.56
2020 Hampson AJ, Schroeder JR, Ellefsen KN, Yammine L, Epstein DH, Preston KL, Huestis MA, Verrico CD. Sub-Therapeutic Acetazolamide Doses as a Non-Invasive Method for Assessing Medication Adherence. Clinical Pharmacology and Therapeutics. PMID 32496573 DOI: 10.1002/cpt.1929  0.44
2020 Huestis MA, Sempio C, Newmeyer MN, Andersson M, Barnes AJ, Abulseoud OA, Blount BC, Schroeder J, Smith ML. Free and Glucuronide Urine Cannabinoids after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users. Journal of Analytical Toxicology. PMID 32369162 DOI: 10.1093/jat/bkaa046  0.52
2020 Loflin MJE, Kiluk BD, Huestis MA, Aklin WM, Budney AJ, Carroll KM, D'Souza DC, Dworkin RH, Gray KM, Hasin DS, Lee DC, Le Foll B, Levin FR, Lile JA, Mason BJ, et al. The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda. Drug and Alcohol Dependence. 107993. PMID 32360455 DOI: 10.1016/j.drugalcdep.2020.107993  0.36
2020 Farokhnia M, McDiarmid GR, Newmeyer MN, Munjal V, Abulseoud OA, Huestis MA, Leggio L. Effects of oral, smoked, and vaporized cannabis on endocrine pathways related to appetite and metabolism: a randomized, double-blind, placebo-controlled, human laboratory study. Translational Psychiatry. 10: 71. PMID 32075958 DOI: 10.1038/s41398-020-0756-3  0.4
2019 Bonn-Miller MO, Pollack CV, Casarett D, Dart R, ElSohly M, Good L, Guzmán M, Hanuš L, Hill KP, Huestis MA, Marsh E, Sisley S, Skinner N, Spahr J, Vandrey R, et al. Priority Considerations for Medicinal Cannabis-Related Research. Cannabis and Cannabinoid Research. 4: 139-157. PMID 31579832 DOI: 10.1089/can.2019.0045  0.36
2019 Hubbard JA, Smith BE, Sobolesky PM, Kim S, Hoffman MA, Stone J, Huestis MA, Grelotti DJ, Grant I, Marcotte TS, Fitzgerald RL. Validation of a liquid chromatography tandem mass spectrometry (LC-MS/MS) method to detect cannabinoids in whole blood and breath. Clinical Chemistry and Laboratory Medicine. PMID 31527291 DOI: 10.1515/cclm-2019-0600  0.32
2019 Desrosiers NA, Huestis MA. Oral Fluid Drug Testing: Analytical Approaches, Issues and Interpretation of Results. Journal of Analytical Toxicology. PMID 31263897 DOI: 10.1093/jat/bkz048  0.44
2019 Baggott MJ, Garrison KJ, Coyle JR, Galloway GP, Barnes AJ, Huestis MA, Mendelson JE. Effects of the Psychedelic Amphetamine MDA (3,4-Methylenedioxyamphetamine) in Healthy Volunteers. Journal of Psychoactive Drugs. 1-10. PMID 30967099 DOI: 10.1080/02791072.2019.1593560  0.52
2019 Huestis MA, Blount BC, Milan DF, Newmeyer MN, Schroeder J, Smith ML. Correlation of Creatinine- and Specific Gravity-Normalized Free & Glucuronidated Urine Cannabinoid Concentrations Following Smoked, Vaporized and Oral Cannabis in Frequent and Occasional Cannabis Users. Drug Testing and Analysis. PMID 30756523 DOI: 10.1002/dta.2576  0.4
2018 Carlier J, Wohlfarth A, Salmeron BD, Scheidweiler KB, Huestis MA, Baumann MH. Pharmacodynamic effects, pharmacokinetics, and metabolism of the synthetic cannabinoid AM-2201 in male rats. The Journal of Pharmacology and Experimental Therapeutics. PMID 30266766 DOI: 10.1124/jpet.118.250530  0.44
2018 Hirvonen J, Zanotti-Fregonara P, Gorelick DA, Lyoo CH, Rallis-Frutos D, Morse C, Zoghbi SS, Pike VW, Volkow ND, Huestis MA, Innis RB. Decreased Cannabinoid CB Receptors in Male Tobacco Smokers Examined With Positron Emission Tomography. Biological Psychiatry. PMID 30121138 DOI: 10.1016/j.biopsych.2018.07.009  0.56
2018 Concheiro M, Huestis MA. Drug exposure during pregnancy: analytical methods and toxicological findings. Bioanalysis. PMID 29561633 DOI: 10.4155/bio-2017-0260  0.32
2018 Huestis MA, Smith ML. Cannabinoid Markers in Biological Fluids and Tissues: Revealing Intake. Trends in Molecular Medicine. PMID 29398403 DOI: 10.1016/j.molmed.2017.12.006  0.36
2018 Trigo JM, Soliman A, Quilty LC, Fischer B, Rehm J, Selby P, Barnes AJ, Huestis MA, George TP, Streiner DL, Staios G, Le Foll B. Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial. Plos One. 13: e0190768. PMID 29385147 DOI: 10.1371/journal.pone.0190768  0.52
2017 Logan BK, D'Orazio AL, Mohr ALA, Limoges JF, Miles AK, Scarneo CE, Kerrigan S, Liddicoat LJ, Scott KS, Huestis MA. Recommendations for Toxicological Investigation of Drug-Impaired Driving and Motor Vehicle Fatalities-2017 Update. Journal of Analytical Toxicology. 1-6. PMID 29186455 DOI: 10.1093/jat/bkx082  0.36
2017 Bouhlal S, Ellefsen KN, Sheskier MB, Singley E, Pirard S, Gorelick DA, Huestis MA, Leggio L. Acute effects of intravenous cocaine administration on serum concentrations of ghrelin, amylin, glucagon-like peptide-1, insulin, leptin and peptide YY and relationships with cardiorespiratory and subjective responses. Drug and Alcohol Dependence. 180: 68-75. PMID 28881319 DOI: 10.1016/j.drugalcdep.2017.07.033  0.56
2017 Sempio C, Scheidweiler KB, Barnes AJ, Huestis MA. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry. Drug Testing and Analysis. PMID 28815938 DOI: 10.1002/dta.2230  0.52
2017 Logan BK, Mohr ALA, Friscia M, Krotulski AJ, Papsun DM, Kacinko SL, Ropero-Miller JD, Huestis MA. Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013-2016: A Review. Journal of Analytical Toxicology. 1-38. PMID 28459969 DOI: 10.1093/jat/bkx031  0.52
2017 Newmeyer MN, Swortwood MJ, Abulseoud OA, Huestis MA. Subjective and physiological effects, and expired carbon monoxide concentrations in frequent and occasional cannabis smokers following smoked, vaporized, and oral cannabis administration. Drug and Alcohol Dependence. 175: 67-76. PMID 28407543 DOI: 10.1016/j.drugalcdep.2017.02.003  0.4
2017 Carlier J, Diao X, Scheidweiler KB, Huestis MA. Distinguishing Intake of New Synthetic Cannabinoids ADB-PINACA and 5F-ADB-PINACA with Human Hepatocyte Metabolites and High-Resolution Mass Spectrometry. Clinical Chemistry. PMID 28302730 DOI: 10.1373/clinchem.2016.267575  0.44
2017 Lee MR, Scheidweiler KB, Diao XX, Akhlaghi F, Cummins A, Huestis MA, Leggio L, Averbeck BB. Oxytocin by intranasal and intravenous routes reaches the cerebrospinal fluid in rhesus macaques: determination using a novel oxytocin assay. Molecular Psychiatry. PMID 28289281 DOI: 10.1038/mp.2017.27  0.44
2017 Diao X, Carlier J, Zhu M, Pang S, Kronstrand R, Scheidweiler KB, Huestis MA. In vitro and in vivo human metabolism of a new synthetic cannabinoid NM-2201 (CBL-2201). Forensic Toxicology. 35: 20-32. PMID 28286577 DOI: 10.1007/s11419-016-0326-9  0.44
2017 Newmeyer MN, Swortwood MJ, Andersson M, Abulseoud OA, Scheidweiler KB, Huestis MA. Cannabis Edibles: Blood and Oral Fluid Cannabinoid Pharmacokinetics and Evaluation of Oral Fluid Screening Devices for Predicting Δ(9)-Tetrahydrocannabinol in Blood and Oral Fluid following Cannabis Brownie Administration. Clinical Chemistry. PMID 28188235 DOI: 10.1373/clinchem.2016.265371  0.44
2017 Newmeyer MN, Swortwood MJ, Taylor ME, Abulseoud OA, Woodward TH, Huestis MA. Evaluation of divided attention psychophysical task performance and effects on pupil sizes following smoked, vaporized and oral cannabis administration. Journal of Applied Toxicology : Jat. PMID 28138971 DOI: 10.1002/jat.3440  0.4
2016 Newmeyer MN, Swortwood MJ, Barnes AJ, Abulseoud OA, Scheidweiler KB, Huestis MA. Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake. Clinical Chemistry. 62: 1579-1592. PMID 27899456 DOI: 10.1373/clinchem.2016.263475  0.52
2016 Wiegand SL, Swortwood MJ, Huestis MA, Thorp J, Jones HE, Vora NL. Naloxone and Metabolites Quantification in Cord Blood of Prenatally Exposed Newborns and Correlations with Maternal Concentrations. Ajp Reports. 6: e385-e390. PMID 27896019 DOI: 10.1055/s-0036-1593993  0.36
2016 Baumann MH, Bukhari MO, Lehner KR, Anizan S, Rice KC, Concheiro M, Huestis MA. Neuropharmacology of 3,4-Methylenedioxypyrovalerone (MDPV), Its Metabolites, and Related Analogs. Current Topics in Behavioral Neurosciences. PMID 27830575 DOI: 10.1007/7854_2016_53  0.32
2016 Elmore J, Dillon-Carter O, Partilla J, Ellefsen KN, Concheiro M, Suzuki M, Rice KC, Huestis MA, Baumann MH. Pharmacokinetic Profiles and Pharmacodynamic Effects for Methylone and its Metabolites in Rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 27658484 DOI: 10.1038/npp.2016.213  0.32
2016 Swortwood MJ, Newmeyer MN, Abulseoud OA, Scheidweiler KB, Huestis MA. Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration. Drug Testing and Analysis. PMID 27647820 DOI: 10.1002/dta.2092  0.44
2016 Wilsey BL, Deutsch R, Samara E, Marcotte TD, Barnes AJ, Huestis MA, Le D. A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis. Journal of Pain Research. 9: 587-98. PMID 27621666 DOI: 10.2147/JPR.S113138  0.52
2016 Jansson LM, Spencer N, McConnell K, Velez M, Tuten M, Harrow CA, Jones HE, Swortwood MJ, Barnes AJ, Scheidweiler KB, Huestis MA. Maternal Buprenorphine Maintenance and Lactation. Journal of Human Lactation : Official Journal of International Lactation Consultant Association. PMID 27563013 DOI: 10.1177/0890334416663198  0.52
2016 Diao X, Scheidweiler KB, Wohlfarth A, Zhu M, Pang S, Huestis MA. Strategies to distinguish new synthetic cannabinoid FUBIMINA (BIM-2201) intake from its isomer THJ-2201: metabolism of FUBIMINA in human hepatocytes. Forensic Toxicology. 34: 256-267. PMID 27547265 DOI: 10.1007/s11419-016-0312-2  0.44
2016 Scheidweiler KB, Andersson M, Swortwood MJ, Sempio C, Huestis MA. Long term stability of cannabinoids in oral fluid after controlled cannabis administration. Drug Testing and Analysis. PMID 27539096 DOI: 10.1002/dta.2056  0.44
2016 Andersson M, Scheidweiler KB, Sempio C, Barnes AJ, Huestis MA. Simultaneous quantification of 11 cannabinoids and metabolites in human urine by liquid chromatography tandem mass spectrometry using WAX-S tips. Analytical and Bioanalytical Chemistry. PMID 27422645 DOI: 10.1007/s00216-016-9765-8  0.52
2016 Baggott MJ, Garrison KJ, Coyle JR, Galloway GP, Barnes AJ, Huestis MA, Mendelson JE. MDMA Impairs Response to Water Intake in Healthy Volunteers. Advances in Pharmacological Sciences. 2016: 2175896. PMID 27403159 DOI: 10.1155/2016/2175896  0.96
2016 Trigo JM, Soliman A, Staios G, Quilty L, Fischer B, George TP, Rehm J, Selby P, Barnes AJ, Huestis MA, Le Foll B. Sativex Associated With Behavioral-Relapse Prevention Strategy as Treatment for Cannabis Dependence: A Case Series. Journal of Addiction Medicine. PMID 27261670 DOI: 10.1097/ADM.0000000000000229  0.52
2016 Ellefsen KN, Concheiro M, Huestis MA. Synthetic cathinone pharmacokinetics, analytical methods, and toxicological findings from human performance and postmortem cases. Drug Metabolism Reviews. 1-29. PMID 27249313 DOI: 10.1080/03602532.2016.1188937  0.32
2016 Scheidweiler KB, Newmeyer MN, Barnes AJ, Huestis MA. Quantification of cannabinoids and their free and glucuronide metabolites in whole blood by disposable pipette extraction and liquid chromatography-tandem mass spectrometry. Journal of Chromatography. A. PMID 27236483 DOI: 10.1016/j.chroma.2016.05.024  0.52
2016 Carlier J, Scheidweiler KB, Wohlfarth A, Salmeron BD, Baumann MH, Huestis MA. Quantification of [1-(5-fluoropentyl)-1H-indol-3-yl](naphthalene-1-yl)methanone (AM-2201) and 13 metabolites in human and rat plasma by liquid chromatography-tandem mass spectrometry. Journal of Chromatography. A. PMID 27208987 DOI: 10.1016/j.chroma.2016.05.020  0.44
2016 Swortwood MJ, Ellefsen KN, Wohlfarth A, Diao X, Concheiro-Guisan M, Kronstrand R, Huestis MA. First metabolic profile of PV8, a novel synthetic cathinone, in human hepatocytes and urine by high-resolution mass spectrometry. Analytical and Bioanalytical Chemistry. PMID 27185540 DOI: 10.1007/s00216-016-9599-4  0.52
2016 Ellefsen KN, Concheiro M, Pirard S, Gorelick DA, Huestis MA. Pharmacodynamic effects and relationships to plasma and oral fluid pharmacokinetics after intravenous cocaine administration. Drug and Alcohol Dependence. PMID 27114201 DOI: 10.1016/j.drugalcdep.2016.04.004  0.56
2016 Swortwood MJ, Scheidweiler KB, Barnes AJ, Jansson LM, Huestis MA. Simultaneous quantification of buprenorphine, naloxone and phase I and II metabolites in plasma and breastmilk by liquid chromatography-tandem mass spectrometry. Journal of Chromatography. A. PMID 27083254 DOI: 10.1016/j.chroma.2016.03.076  0.96
2016 Andersson M, Diao X, Wohlfarth A, Scheidweiler KB, Huestis MA. Metabolic profiling of new synthetic cannabinoids AMB and 5F-AMB by human hepatocyte and liver microsome incubations and high-resolution mass spectrometry. Rapid Communications in Mass Spectrometry : Rcm. 30: 1067-78. PMID 27003044 DOI: 10.1002/rcm.7538  0.44
2016 Ellefsen KN, Concheiro M, Pirard S, Gorelick DA, Huestis MA. Cocaine and benzoylecgonine oral fluid on-site screening and confirmation. Drug Testing and Analysis. PMID 26968560 DOI: 10.1002/dta.1966  0.96
2016 Trigo JM, Lagzdins D, Rehm J, Selby P, Gamaleddin I, Fischer B, Barnes AJ, Huestis MA, Le Foll B. Effects of fixed or self-titrated dosages of Sativex on cannabis withdrawal and cravings. Drug and Alcohol Dependence. 161: 298-306. PMID 26925704 DOI: 10.1016/j.drugalcdep.2016.02.020  0.52
2016 Hartman RL, Brown TL, Milavetz G, Spurgin A, Pierce RS, Gorelick DA, Gaffney G, Huestis MA. Cannabis effects on driving longitudinal control with and without alcohol. Journal of Applied Toxicology : Jat. PMID 26889769 DOI: 10.1002/jat.3295  0.96
2016 Ellefsen KN, Concheiro M, Pirard S, Gorelick DA, Huestis MA. Oral fluid cocaine and benzoylecgonine concentrations following controlled intravenous cocaine administration. Forensic Science International. 260: 95-101. PMID 26851651 DOI: 10.1016/j.forsciint.2016.01.013  0.96
2016 Hartman RL, Brown TL, Milavetz G, Spurgin A, Gorelick DA, Gaffney GR, Huestis MA. Effect of Blood Collection Time on Measured Δ9-Tetrahydrocannabinol Concentrations: Implications for Driving Interpretation and Drug Policy. Clinical Chemistry. 62: 367-77. PMID 26823611 DOI: 10.1373/clinchem.2015.248492  0.56
2016 Diao X, Scheidweiler KB, Wohlfarth A, Pang S, Kronstrand R, Huestis MA. In Vitro and In Vivo Human Metabolism of Synthetic Cannabinoids FDU-PB-22 and FUB-PB-22. The Aaps Journal. PMID 26810398 DOI: 10.1208/s12248-016-9867-4  0.44
2016 Ellefsen KN, Wohlfarth A, Swortwood MJ, Diao X, Concheiro M, Huestis MA. 4-Methoxy-α-PVP: in silico prediction, metabolic stability, and metabolite identification by human hepatocyte incubation and high-resolution mass spectrometry. Forensic Toxicology. 34: 61-75. PMID 26793277 DOI: 10.1007/s11419-015-0287-4  0.96
2016 Swortwood MJ, Carlier J, Ellefsen KN, Wohlfarth A, Diao X, Concheiro-Guisan M, Kronstrand R, Huestis MA. In vitro, in vivo and in silico metabolic profiling of α-pyrrolidinopentiothiophenone, a novel thiophene stimulant. Bioanalysis. 8: 65-82. PMID 26648097 DOI: 10.4155/bio.15.237  0.96
2016 Hartman RL, Brown TL, Milavetz G, Spurgin A, Gorelick DA, Gaffney GR, Huestis MA. Effect of blood collection time on measured δ9-Tetrahydrocannabinol concentrations: Implications for driving interpretation and drug policy Clinical Chemistry. 62: 367-377. DOI: 10.1373/clinchem.2015.248492  0.96
2016 Diao X, Scheidweiler KB, Wohlfarth A, Zhu M, Pang S, Huestis MA. Strategies to distinguish new synthetic cannabinoid FUBIMINA (BIM-2201) intake from its isomer THJ-2201: metabolism of FUBIMINA in human hepatocytes Forensic Toxicology. 1-12. DOI: 10.1007/s11419-016-0312-2  0.44
2015 Vaupel DB, Schindler CW, Chefer S, Belcher AM, Ahmet I, Scheidweiler KB, Huestis MA, Stein EA. Delayed emergence of methamphetamine's enhanced cardiovascular effects in nonhuman primates during protracted methamphetamine abstinence. Drug and Alcohol Dependence. PMID 26775284 DOI: 10.1016/j.drugalcdep.2015.12.008  0.44
2015 Diao X, Wohlfarth A, Pang S, Scheidweiler KB, Huestis MA. High-Resolution Mass Spectrometry for Characterizing the Metabolism of Synthetic Cannabinoid THJ-018 and Its 5-Fluoro Analog THJ-2201 after Incubation in Human Hepatocytes. Clinical Chemistry. PMID 26430074 DOI: 10.1373/clinchem.2015.243535  0.96
2015 Lee D, Bergamaschi MM, Milman G, Barnes AJ, Queiroz RH, Vandrey R, Huestis MA. Plasma Cannabinoid Pharmacokinetics After Controlled Smoking and Ad libitum Cannabis Smoking in Chronic Frequent Users. Journal of Analytical Toxicology. 39: 580-7. PMID 26378131 DOI: 10.1093/jat/bkv082  0.96
2015 Marin SJ, Doyle K, Chang A, Concheiro-Guisan M, Huestis MA, Johnson-Davis KL. One Hundred False-Positive Amphetamine Specimens Characterized by Liquid Chromatography Time-of-Flight Mass Spectrometry. Journal of Analytical Toxicology. PMID 26342055 DOI: 10.1093/jat/bkv101  0.52
2015 Wohlfarth A, Scheidweiler KB, Pang S, Zhu M, Castaneto M, Kronstrand R, Huestis MA. Metabolic characterization of AH-7921, a synthetic opioid designer drug: in vitro metabolic stability assessment and metabolite identification, evaluation of in silico prediction, and in vivo confirmation. Drug Testing and Analysis. PMID 26331297 DOI: 10.1002/dta.1856  0.96
2015 Ellefsen KN, da Costa JL, Concheiro M, Anizan S, Barnes AJ, Pirard S, Gorelick DA, Huestis MA. Cocaine and metabolite concentrations in DBS and venous blood after controlled intravenous cocaine administration. Bioanalysis. 7: 2041-56. PMID 26327184 DOI: 10.4155/bio.15.127  0.96
2015 Huestis MA. Cannabis-impaired driving: a public health and safety concern. Clinical Chemistry. 61: 1223-5. PMID 26283691 DOI: 10.1373/clinchem.2015.245001  0.96
2015 Huestis MA. Deterring driving under the influence of cannabis. Addiction (Abingdon, England). 110: 1697-8. PMID 26264558 DOI: 10.1111/add.13041  0.96
2015 Hartman RL, Brown TL, Milavetz G, Spurgin A, Gorelick DA, Gaffney G, Huestis MA. Controlled vaporized cannabis, with and without alcohol: subjective effects and oral fluid-blood cannabinoid relationships. Drug Testing and Analysis. PMID 26257143 DOI: 10.1002/dta.1839  0.96
2015 Hartman RL, Brown TL, Milavetz G, Spurgin A, Pierce RS, Gorelick DA, Gaffney G, Huestis MA. Cannabis effects on driving lateral control with and without alcohol. Drug and Alcohol Dependence. PMID 26144593 DOI: 10.1016/j.drugalcdep.2015.06.015  0.96
2015 Karschner EL, Swortwood MJ, Hirvonen J, Goodwin RS, Bosker WM, Ramaekers JG, Huestis MA. Extended plasma cannabinoid excretion in chronic frequent cannabis smokers during sustained abstinence and correlation with psychomotor performance. Drug Testing and Analysis. PMID 26097154 DOI: 10.1002/dta.1825  0.96
2015 Hartman RL, Brown TL, Milavetz G, Spurgin A, Gorelick DA, Gaffney G, Huestis MA. Controlled Cannabis Vaporizer Administration: Blood and Plasma Cannabinoids with and without Alcohol. Clinical Chemistry. 61: 850-69. PMID 26019183 DOI: 10.1373/clinchem.2015.238287  0.96
2015 Himes SK, Huo Y, Siberry GK, Williams PL, Rice ML, Sirois PA, Frederick T, Hazra R, Huestis MA. Meconium Atazanavir Concentrations and Early Language Outcomes in HIV-Exposed Uninfected Infants With Prenatal Atazanavir Exposure. Journal of Acquired Immune Deficiency Syndromes (1999). 69: 178-86. PMID 26009830 DOI: 10.1097/QAI.0000000000000558  0.96
2015 Himes SK, Tassiopoulos K, Yogev R, Huestis MA. Antiretroviral Drugs in Meconium: Detection for Different Gestational Periods of Exposure. The Journal of Pediatrics. 167: 305-11.e3. PMID 26001315 DOI: 10.1016/j.jpeds.2015.04.062  0.96
2015 Battal D, Barnes AJ, Castaneto MS, Martin TM, Klette KL, Huestis MA. Urine mescaline screening with a biochip array immunoassay and quantification by gas chromatography-mass spectrometry. Therapeutic Drug Monitoring. PMID 25992796 DOI: 10.1097/FTD.0000000000000220  0.96
2015 Himes SK, Wu JW, Jacobson DL, Tassiopoulos K, Hazra R, Kacanek D, Van Dyke RB, Rich KC, Siberry GK, Huestis MA. Meconium Tenofovir Concentrations and Growth and Bone Outcomes in Prenatally Tenofovir Exposed HIV-Uninfected Children. The Pediatric Infectious Disease Journal. 34: 851-7. PMID 25961889 DOI: 10.1097/INF.0000000000000747  0.96
2015 Concheiro M, Castaneto M, Kronstrand R, Huestis MA. Simultaneous determination of 40 novel psychoactive stimulants in urine by liquid chromatography-high resolution mass spectrometry and library matching. Journal of Chromatography. A. 1397: 32-42. PMID 25931378 DOI: 10.1016/j.chroma.2015.04.002  0.96
2015 Castaneto MS, Barnes AJ, Concheiro M, Klette KL, Martin TA, Huestis MA. Biochip array technology immunoassay performance and quantitative confirmation of designer piperazines for urine workplace drug testing. Analytical and Bioanalytical Chemistry. 407: 4639-48. PMID 25903022 DOI: 10.1007/s00216-015-8660-z  0.96
2015 Castaneto MS, Wohlfarth A, Desrosiers NA, Hartman RL, Gorelick DA, Huestis MA. Synthetic cannabinoids pharmacokinetics and detection methods in biological matrices. Drug Metabolism Reviews. 47: 124-74. PMID 25853390 DOI: 10.3109/03602532.2015.1029635  0.96
2015 Newmeyer MN, Concheiro M, da Costa JL, Flegel R, Gorelick DA, Huestis MA. Oral fluid with three modes of collection and plasma methamphetamine and amphetamine enantiomer concentrations after controlled intranasal l-methamphetamine administration. Drug Testing and Analysis. PMID 25786659 DOI: 10.1002/dta.1784  0.96
2015 Manini AF, Yiannoulos G, Bergamaschi MM, Hernandez S, Olmedo R, Barnes AJ, Winkel G, Sinha R, Jutras-Aswad D, Huestis MA, Hurd YL. Safety and pharmacokinetics of oral cannabidiol when administered concomitantly with intravenous fentanyl in humans. Journal of Addiction Medicine. 9: 204-10. PMID 25748562 DOI: 10.1097/ADM.0000000000000118  0.52
2015 Desrosiers NA, Ramaekers JG, Chauchard E, Gorelick DA, Huestis MA. Smoked cannabis' psychomotor and neurocognitive effects in occasional and frequent smokers. Journal of Analytical Toxicology. 39: 251-61. PMID 25745105 DOI: 10.1093/jat/bkv012  0.96
2015 Wohlfarth A, Castaneto MS, Zhu M, Pang S, Scheidweiler KB, Kronstrand R, Huestis MA. Pentylindole/Pentylindazole Synthetic Cannabinoids and Their 5-Fluoro Analogs Produce Different Primary Metabolites: Metabolite Profiling for AB-PINACA and 5F-AB-PINACA. The Aaps Journal. 17: 660-77. PMID 25721194 DOI: 10.1208/s12248-015-9721-0  0.96
2015 Barnes AJ, Spinelli E, Young S, Martin TM, Kleete KL, Huestis MA. Validation of an ELISA Synthetic Cannabinoids Urine Assay. Therapeutic Drug Monitoring. PMID 25706046 DOI: 10.1097/FTD.0000000000000201  0.96
2015 Eiden RD, Molnar DS, Granger DA, Colder CR, Schuetze P, Huestis MA. Prenatal tobacco exposure and infant stress reactivity: role of child sex and maternal behavior. Developmental Psychobiology. 57: 212-25. PMID 25650169 DOI: 10.1002/dev.21284  0.96
2015 Himes SK, Dukes KA, Tripp T, Petersen JM, Raffo C, Burd L, Odendaal H, Elliott AJ, Hereld D, Signore C, Willinger M, Huestis MA. Clinical sensitivity and specificity of meconium fatty acid ethyl ester, ethyl glucuronide, and ethyl sulfate for detecting maternal drinking during pregnancy. Clinical Chemistry. 61: 523-32. PMID 25595440 DOI: 10.1373/clinchem.2014.233718  0.96
2015 Desrosiers NA, Scheidweiler KB, Huestis MA. Quantification of six cannabinoids and metabolites in oral fluid by liquid chromatography-tandem mass spectrometry. Drug Testing and Analysis. 7: 684-94. PMID 25428610 DOI: 10.1002/dta.1753  0.96
2015 Kwako LE, Spagnolo PA, Schwandt ML, Thorsell A, George DT, Momenan R, Rio DE, Huestis M, Anizan S, Concheiro M, Sinha R, Heilig M. The corticotropin releasing hormone-1 (CRH1) receptor antagonist pexacerfont in alcohol dependence: a randomized controlled experimental medicine study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1053-63. PMID 25409596 DOI: 10.1038/npp.2014.306  0.96
2015 Concheiro M, Newmeyer MN, da Costa JL, Flegel R, Gorelick DA, Huestis MA. Morphine and codeine in oral fluid after controlled poppy seed administration. Drug Testing and Analysis. 7: 586-91. PMID 25345619 DOI: 10.1002/dta.1742  0.96
2015 Wohlfarth A, Scheidweiler KB, Castaneto M, Gandhi AS, Desrosiers NA, Klette KL, Martin TM, Huestis MA. Urinary prevalence, metabolite detection rates, temporal patterns and evaluation of suitable LC-MS/MS targets to document synthetic cannabinoid intake in US military urine specimens. Clinical Chemistry and Laboratory Medicine : Cclm / Fescc. 53: 423-34. PMID 25263309 DOI: 10.1515/cclm-2014-0612  0.96
2015 Castaneto MS, Scheidweiler KB, Gandhi A, Wohlfarth A, Klette KL, Martin TM, Huestis MA. Quantitative urine confirmatory testing for synthetic cannabinoids in randomly collected urine specimens. Drug Testing and Analysis. 7: 483-93. PMID 25231213 DOI: 10.1002/dta.1709  0.96
2015 Scheidweiler KB, Jarvis MJ, Huestis MA. Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry. Analytical and Bioanalytical Chemistry. 407: 883-97. PMID 25224637 DOI: 10.1007/s00216-014-8118-8  0.96
2015 Lee D, Vandrey R, Mendu DR, Murray JA, Barnes AJ, Huestis MA. Oral fluid cannabinoids in chronic frequent cannabis smokers during ad libitum cannabis smoking. Drug Testing and Analysis. 7: 494-501. PMID 25220020 DOI: 10.1002/dta.1718  0.96
2015 Spinelli E, Barnes AJ, Young S, Castaneto MS, Martin TM, Klette KL, Huestis MA. Performance characteristics of an ELISA screening assay for urinary synthetic cannabinoids. Drug Testing and Analysis. 7: 467-74. PMID 25167963 DOI: 10.1002/dta.1702  0.96
2015 Anizan S, Bergamaschi MM, Barnes AJ, Milman G, Desrosiers N, Lee D, Gorelick DA, Huestis MA. Impact of oral fluid collection device on cannabinoid stability following smoked cannabis. Drug Testing and Analysis. 7: 114-20. PMID 24995604 DOI: 10.1002/dta.1688  0.96
2015 Gandhi AS, Wohlfarth A, Zhu M, Pang S, Castaneto M, Scheidweiler KB, Huestis MA. High-resolution mass spectrometric metabolite profiling of a novel synthetic designer drug, N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135), using cryopreserved human hepatocytes and assessment of metabolic stability with human liver microsomes. Drug Testing and Analysis. 7: 187-98. PMID 24827428 DOI: 10.1002/dta.1662  0.96
2015 Schuetze P, Lessard J, Colder CR, Maiorana N, Shisler S, Eiden RD, Huestis MA, Henrie J. Physiological reactivity during object manipulation among cigarette-exposed infants at 9months of age Neurotoxicology and Teratology. 48: 64-68. DOI: 10.1016/j.ntt.2015.02.001  0.96
2015 Scheidweiler KB, Himes SK, Desrosiers NA, Huestis MA. In vitro stability of free and glucuronidated cannabinoids in blood and plasma collected in plastic gray-top sodium fluoride tubes following controlled smoked cannabis Forensic Toxicology. DOI: 10.1007/s11419-015-0290-9  0.96
2015 Castaneto MS, Wohlfarth A, Pang S, Zhu M, Scheidweiler KB, Kronstrand R, Huestis MA. Identification of AB-FUBINACA metabolites in human hepatocytes and urine using high-resolution mass spectrometry Forensic Toxicology. 33: 295-310. DOI: 10.1007/s11419-015-0275-8  0.96
2015 Hartman RL, Anizan S, Jang M, Brown TL, Yun K, Gorelick DA, Milavetz G, Spurgin A, Gaffney G, Huestis MA. Cannabinoid disposition in oral fluid after controlled vaporizer administration with and without alcohol Forensic Toxicology. DOI: 10.1007/s11419-015-0269-6  0.96
2015 Newmeyer MN, Concheiro M, da Costa JL, LoDico C, Gorelick DA, Huestis MA. Simultaneous plasma and oral fluid morphine and codeine concentrations after controlled administration of poppy seeds with known opiate content Forensic Toxicology. 33: 235-243. DOI: 10.1007/s11419-015-0266-9  0.96
2015 Ellefsen KN, Concheiro M, Suzuki M, Rice KC, Elmore JS, Baumann MH, Huestis MA. Quantification of methylone and metabolites in rat and human plasma by liquid chromatography-tandem mass spectrometry Forensic Toxicology. 33: 202-212. DOI: 10.1007/s11419-015-0263-z  0.96
2014 Kuwabara H, Heishman SJ, Brasic JR, Contoreggi C, Cascella N, Mackowick KM, Taylor R, Rousset O, Willis W, Huestis MA, Concheiro M, Wand G, Wong DF, Volkow ND. Mu Opioid Receptor Binding Correlates with Nicotine Dependence and Reward in Smokers. Plos One. 9: e113694. PMID 25493427 DOI: 10.1371/journal.pone.0113694  0.96
2014 Castaneto MS, Desrosiers NA, Ellefsen K, Anizan S, Martin TM, Klette KL, Huestis MA. Method validation of the biochip array technology for synthetic cannabinoids detection in urine. Bioanalysis. 6: 2919-30. PMID 25486237 DOI: 10.4155/bio.14.150  0.96
2014 Anizan S, Concheiro M, Lehner KR, Bukhari MO, Suzuki M, Rice KC, Baumann MH, Huestis MA. Linear pharmacokinetics of 3,4-methylenedioxypyrovalerone (MDPV) and its metabolites in the rat: relationship to pharmacodynamic effects. Addiction Biology. PMID 25475011 DOI: 10.1111/adb.12201  0.96
2014 Huestis MA. Commentary. Clinical Chemistry. 60: 1484-5. PMID 25432994 DOI: 10.1373/clinchem.2014.224543  0.96
2014 Hartman RL, Huestis MA. Re: "trends in alcohol and other drugs detected in fatally injured drivers in the United States, 1999-2010". American Journal of Epidemiology. 180: 862-3. PMID 25245042 DOI: 10.1093/aje/kwu251  0.96
2014 Castaneto MS, Gorelick DA, Desrosiers NA, Hartman RL, Pirard S, Huestis MA. Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. Drug and Alcohol Dependence. 144: 12-41. PMID 25220897 DOI: 10.1016/j.drugalcdep.2014.08.005  0.96
2014 Smith ML, Nichols DC, Underwood P, Fuller Z, Moser MA, Flegel R, Gorelick DA, Newmeyer MN, Concheiro M, Huestis MA. Methamphetamine and amphetamine isomer concentrations in human urine following controlled Vicks VapoInhaler administration. Journal of Analytical Toxicology. 38: 524-7. PMID 25217541 DOI: 10.1093/jat/bku077  0.96
2014 Ellefsen KN, Concheiro M, Beck O, Gorelick DA, Pirard S, Huestis MA. Quantification of cocaine and metabolites in exhaled breath by liquid chromatography-high-resolution mass spectrometry following controlled administration of intravenous cocaine. Analytical and Bioanalytical Chemistry. 406: 6213-23. PMID 25129634 DOI: 10.1007/s00216-014-8051-x  0.96
2014 Newmeyer MN, Concheiro M, Huestis MA. Rapid quantitative chiral amphetamines liquid chromatography-tandem mass spectrometry: method in plasma and oral fluid with a cost-effective chiral derivatizing reagent. Journal of Chromatography. A. 1358: 68-74. PMID 25065924 DOI: 10.1016/j.chroma.2014.06.096  0.96
2014 Gandhi AS, Zhu M, Pang S, Wohlfarth A, Scheidweiler KB, Huestis MA. Metabolite profiling of RCS-4, a novel synthetic cannabinoid designer drug, using human hepatocyte metabolism and TOF-MS. Bioanalysis. 6: 1471-85. PMID 25046048 DOI: 10.4155/bio.14.13  0.96
2014 Himes SK, Huestis MA. In reply. Clinical Chemistry. 60: 1236-7. PMID 25037935 DOI: 10.1373/clinchem.2014.227561  0.96
2014 Stroud LR, Papandonatos GD, Rodriguez D, McCallum M, Salisbury AL, Phipps MG, Lester B, Huestis MA, Niaura R, Padbury JF, Marsit CJ. Maternal smoking during pregnancy and infant stress response: test of a prenatal programming hypothesis. Psychoneuroendocrinology. 48: 29-40. PMID 24999830 DOI: 10.1016/j.psyneuen.2014.05.017  0.96
2014 Wohlfarth A, Pang S, Zhu M, Gandhi AS, Scheidweiler KB, Huestis MA. Metabolism of RCS-8, a synthetic cannabinoid with cyclohexyl structure, in human hepatocytes by high-resolution MS. Bioanalysis. 6: 1187-200. PMID 24946920 DOI: 10.4155/bio.14.1  0.96
2014 Smith ML, Nichols DC, Underwood P, Fuller Z, Moser MA, LoDico C, Gorelick DA, Newmeyer MN, Concheiro M, Huestis MA. Morphine and codeine concentrations in human urine following controlled poppy seeds administration of known opiate content. Forensic Science International. 241: 87-90. PMID 24887324 DOI: 10.1016/j.forsciint.2014.04.042  0.96
2014 Barnes AJ, Young S, Spinelli E, Martin TM, Klette KL, Huestis MA. Evaluation of a homogenous enzyme immunoassay for the detection of synthetic cannabinoids in urine. Forensic Science International. 241: 27-34. PMID 24845968 DOI: 10.1016/j.forsciint.2014.04.020  0.96
2014 Anizan S, Ellefsen K, Concheiro M, Suzuki M, Rice KC, Baumann MH, Huestis MA. 3,4-Methylenedioxypyrovalerone (MDPV) and metabolites quantification in human and rat plasma by liquid chromatography-high resolution mass spectrometry. Analytica Chimica Acta. 827: 54-63. PMID 24832995 DOI: 10.1016/j.aca.2014.04.015  0.32
2014 Desrosiers NA, Milman G, Mendu DR, Lee D, Barnes AJ, Gorelick DA, Huestis MA. Cannabinoids in oral fluid by on-site immunoassay and by GC-MS using two different oral fluid collection devices. Analytical and Bioanalytical Chemistry. 406: 4117-28. PMID 24828976 DOI: 10.1007/s00216-014-7813-9  0.96
2014 Lee D, Schroeder JR, Karschner EL, Goodwin RS, Hirvonen J, Gorelick DA, Huestis MA. Cannabis withdrawal in chronic, frequent cannabis smokers during sustained abstinence within a closed residential environment. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 23: 234-42. PMID 24724880 DOI: 10.1111/j.1521-0391.2014.12088.x  0.96
2014 Ellefsen KN, Anizan S, Castaneto MS, Desrosiers NA, Martin TM, Klette KL, Huestis MA. Validation of the only commercially available immunoassay for synthetic cathinones in urine: Randox Drugs of Abuse V Biochip Array Technology. Drug Testing and Analysis. 6: 728-38. PMID 24659527 DOI: 10.1002/dta.1633  0.96
2014 Newmeyer MN, Desrosiers NA, Lee D, Mendu DR, Barnes AJ, Gorelick DA, Huestis MA. Cannabinoid disposition in oral fluid after controlled cannabis smoking in frequent and occasional smokers. Drug Testing and Analysis. 6: 1002-10. PMID 24652685 DOI: 10.1002/dta.1632  0.96
2014 Diaz SD, Smith LM, LaGasse LL, Derauf C, Newman E, Shah R, Arria A, Huestis MA, Della Grotta S, Dansereau LM, Neal C, Lester BM. Effects of prenatal methamphetamine exposure on behavioral and cognitive findings at 7.5 years of age. The Journal of Pediatrics. 164: 1333-8. PMID 24630350 DOI: 10.1016/j.jpeds.2014.01.053  0.96
2014 Barnes AJ, Scheidweiler KB, Huestis MA. Quantification of 11-nor-9-carboxy-δ9-tetrahydrocannabinol in human oral fluid by gas chromatography-tandem mass spectrometry. Therapeutic Drug Monitoring. 36: 225-33. PMID 24622724 DOI: 10.1097/01.ftd.0000443071.30662.01  0.96
2014 Kiblawi ZN, Smith LM, Diaz SD, LaGasse LL, Derauf C, Newman E, Shah R, Arria A, Huestis M, Haning W, Strauss A, DellaGrotta S, Dansereau LM, Neal C, Lester B. Prenatal methamphetamine exposure and neonatal and infant neurobehavioral outcome: results from the IDEAL study. Substance Abuse. 35: 68-73. PMID 24588296 DOI: 10.1080/08897077.2013.814614  0.96
2014 Wouldes TA, Lagasse LL, Huestis MA, Dellagrotta S, Dansereau LM, Lester BM. Prenatal methamphetamine exposure and neurodevelopmental outcomes in children from 1 to 3 years. Neurotoxicology and Teratology. 42: 77-84. PMID 24566524 DOI: 10.1016/j.ntt.2014.02.004  0.96
2014 Desrosiers NA, Himes SK, Scheidweiler KB, Concheiro-Guisan M, Gorelick DA, Huestis MA. Phase I and II cannabinoid disposition in blood and plasma of occasional and frequent smokers following controlled smoked cannabis. Clinical Chemistry. 60: 631-43. PMID 24563491 DOI: 10.1373/clinchem.2013.216507  0.96
2014 Wohlfarth A, Gandhi AS, Pang S, Zhu M, Scheidweiler KB, Huestis MA. Metabolism of synthetic cannabinoids PB-22 and its 5-fluoro analog, 5F-PB-22, by human hepatocyte incubation and high-resolution mass spectrometry. Analytical and Bioanalytical Chemistry. 406: 1763-80. PMID 24518903 DOI: 10.1007/s00216-014-7668-0  0.96
2014 Himes SK, LaGasse LL, Derauf C, Newman E, Smith LM, Arria AM, Della Grotta SA, Dansereau LM, Abar B, Neal CR, Lester BM, Huestis MA. Risk of neurobehavioral disinhibition in prenatal methamphetamine-exposed young children with positive hair toxicology results. Therapeutic Drug Monitoring. 36: 535-43. PMID 24518561 DOI: 10.1097/FTD.0000000000000049  0.96
2014 Bergamaschi MM, Queiroz RH, Chagas MH, Linares IM, Arrais KC, de Oliveira DC, Queiroz ME, Nardi AE, Huestis MA, Hallak JE, Zuardi AW, Moreira FA, Crippa JA. Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report. Human Psychopharmacology. 29: 94-9. PMID 24424711 DOI: 10.1002/hup.2374  0.96
2014 Scheidweiler KB, Huestis MA. Simultaneous quantification of 20 synthetic cannabinoids and 21 metabolites, and semi-quantification of 12 alkyl hydroxy metabolites in human urine by liquid chromatography-tandem mass spectrometry. Journal of Chromatography. A. 1327: 105-17. PMID 24418231 DOI: 10.1016/j.chroma.2013.12.067  0.96
2014 Himes SK, Concheiro M, Scheidweiler KB, Huestis MA. Validation of a novel method to identify in utero ethanol exposure: simultaneous meconium extraction of fatty acid ethyl esters, ethyl glucuronide, and ethyl sulfate followed by LC-MS/MS quantification. Analytical and Bioanalytical Chemistry. 406: 1945-55. PMID 24408304 DOI: 10.1007/s00216-013-7600-z  0.96
2014 Koola MM, Gorelick DA, McMahon RP, Liu F, Huestis MA, Linthicum J, Feldman SM, Warren KR, Wehring HJ, Kelly DL. Psychiatric symptom differences in people with schizophrenia associated with substantial lifetime substance use but no current substance use disorder. Schizophrenia Research. 152: 315-6. PMID 24333005 DOI: 10.1016/j.schres.2013.11.035  0.96
2014 Desrosiers NA, Lee D, Scheidweiler KB, Concheiro-Guisan M, Gorelick DA, Huestis MA. In vitro stability of free and glucuronidated cannabinoids in urine following controlled smoked cannabis. Analytical and Bioanalytical Chemistry. 406: 785-92. PMID 24292435 DOI: 10.1007/s00216-013-7524-7  0.96
2014 Desrosiers NA, Lee D, Concheiro-Guisan M, Scheidweiler KB, Gorelick DA, Huestis MA. Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers? Clinical Chemistry. 60: 361-72. PMID 24185550 DOI: 10.1373/clinchem.2013.214106  0.96
2014 Anizan S, Huestis MA. The potential role of oral fluid in antidoping testing. Clinical Chemistry. 60: 307-22. PMID 24153253 DOI: 10.1373/clinchem.2013.209676  0.32
2014 Concheiro M, Baumann MH, Scheidweiler KB, Rothman RB, Marrone GF, Huestis MA. Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the rat. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 42: 119-25. PMID 24141857 DOI: 10.1124/dmd.113.053678  0.44
2014 Milman G, Bergamaschi MM, Lee D, Mendu DR, Barnes AJ, Vandrey R, Huestis MA. Plasma cannabinoid concentrations during dronabinol pharmacotherapy for cannabis dependence Therapeutic Drug Monitoring. 36: 218-224. PMID 24067260 DOI: 10.1097/FTD.0b013e3182a5c446  0.96
2014 Lee D, Huestis MA. Current knowledge on cannabinoids in oral fluid. Drug Testing and Analysis. 6: 88-111. PMID 23983217 DOI: 10.1002/dta.1514  0.96
2014 Abar B, LaGasse LL, Wouldes T, Derauf C, Newman E, Shah R, Smith LM, Arria AM, Huestis MA, DellaGrotta S, Dansereau LM, Wilcox T, Neal CR, Lester BM. Cross-national comparison of prenatal methamphetamine exposure on infant and early child physical growth: a natural experiment. Prevention Science : the Official Journal of the Society For Prevention Research. 15: 767-76. PMID 23943149 DOI: 10.1007/s11121-013-0431-5  0.96
2014 Anizan S, Ellefsen K, Concheiro M, Suzuki M, Rice KC, Baumann MH, Huestis MA. 3,4-Methylenedioxypyrovalerone (MDPV) and metabolites quantification in human and rat plasma by liquid chromatography-high resolution mass spectrometry Analytica Chimica Acta. 827: 54-63. DOI: 10.1016/j.aca.2014.04.015  0.96
2013 Castaneto MS, Barnes AJ, Scheidweiler KB, Schaffer M, Rogers KK, Stewart D, Huestis MA. Identifying methamphetamine exposure in children. Therapeutic Drug Monitoring. 35: 823-30. PMID 24263642 DOI: 10.1097/FTD.0b013e31829685b2  0.52
2013 Hartman RL, Desrosiers NA, Barnes AJ, Yun K, Scheidweiler KB, Kolbrich-Spargo EA, Gorelick DA, Goodwin RS, Huestis MA. 3,4-Methylenedioxymethamphetamine (MDMA) and metabolites disposition in blood and plasma following controlled oral administration. Analytical and Bioanalytical Chemistry. PMID 24232751 DOI: 10.1007/s00216-013-7468-y  0.96
2013 Concheiro M, Anizan S, Ellefsen K, Huestis MA. Simultaneous quantification of 28 synthetic cathinones and metabolites in urine by liquid chromatography-high resolution mass spectrometry. Analytical and Bioanalytical Chemistry. 405: 9437-48. PMID 24196122 DOI: 10.1007/s00216-013-7386-z  0.96
2013 Himes SK, Scheidweiler KB, Beck O, Gorelick DA, Desrosiers NA, Huestis MA. Cannabinoids in exhaled breath following controlled administration of smoked cannabis. Clinical Chemistry. 59: 1780-9. PMID 24046200 DOI: 10.1373/clinchem.2013.207407  0.96
2013 Wohlfarth A, Pang S, Zhu M, Gandhi AS, Scheidweiler KB, Liu HF, Huestis MA. First metabolic profile of XLR-11, a novel synthetic cannabinoid, obtained by using human hepatocytes and high-resolution mass spectrometry. Clinical Chemistry. 59: 1638-48. PMID 24014837 DOI: 10.1373/clinchem.2013.209965  0.96
2013 Anizan S, Milman G, Desrosiers N, Barnes AJ, Gorelick DA, Huestis MA. Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers. Analytical and Bioanalytical Chemistry. 405: 8451-61. PMID 23954944 DOI: 10.1007/s00216-013-7291-5  0.96
2013 Gorelick DA, Goodwin RS, Schwilke E, Schroeder JR, Schwope DM, Kelly DL, Ortemann-Renon C, Bonnet D, Huestis MA. Around-the-clock oral THC effects on sleep in male chronic daily cannabis smokers. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 22: 510-4. PMID 23952899 DOI: 10.1111/j.1521-0391.2013.12003.x  0.96
2013 Lee D, Vandrey R, Mendu DR, Anizan S, Milman G, Murray JA, Barnes AJ, Huestis MA. Oral fluid cannabinoids in chronic cannabis smokers during oral δ9-tetrahydrocannabinol therapy and smoked cannabis challenge. Clinical Chemistry. 59: 1770-9. PMID 23938457 DOI: 10.1373/clinchem.2013.207316  0.96
2013 Gandhi AS, Zhu M, Pang S, Wohlfarth A, Scheidweiler KB, Liu HF, Huestis MA. First characterization of AKB-48 metabolism, a novel synthetic cannabinoid, using human hepatocytes and high-resolution mass spectrometry. The Aaps Journal. 15: 1091-8. PMID 23913126 DOI: 10.1208/s12248-013-9516-0  0.96
2013 Lee D, Vandrey R, Milman G, Bergamaschi M, Mendu DR, Murray JA, Barnes AJ, Huestis MA. Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration. Analytical and Bioanalytical Chemistry. 405: 7269-79. PMID 23831756 DOI: 10.1007/s00216-013-7159-8  0.96
2013 Concheiro M, Lee D, Lendoiro E, Huestis MA. Simultaneous quantification of Δ(9)-tetrahydrocannabinol, 11-nor-9-carboxy-tetrahydrocannabinol, cannabidiol and cannabinol in oral fluid by microflow-liquid chromatography-high resolution mass spectrometry. Journal of Chromatography. A. 1297: 123-30. PMID 23726246 DOI: 10.1016/j.chroma.2013.04.071  0.96
2013 Scheidweiler KB, Himes SK, Chen X, Liu HF, Huestis MA. 11-Nor-9-carboxy-∆9-tetrahydrocannabinol quantification in human oral fluid by liquid chromatography-tandem mass spectrometry. Analytical and Bioanalytical Chemistry. 405: 6019-27. PMID 23681203 DOI: 10.1007/s00216-013-7027-6  0.96
2013 Hahn B, Harvey AN, Concheiro-Guisan M, Huestis MA, Holcomb HH, Gold JM. A test of the cognitive self-medication hypothesis of tobacco smoking in schizophrenia. Biological Psychiatry. 74: 436-43. PMID 23660272 DOI: 10.1016/j.biopsych.2013.03.017  0.96
2013 Schuetze P, Eiden RD, Colder CR, Gray TR, Huestis MA. Physiological Regulation at 9 Months of Age in Infants Prenatally Exposed to Cigarettes. Infancy : the Official Journal of the International Society On Infant Studies. 18: 233-255. PMID 23646002 DOI: 10.1111/j.1532-7078.2012.00118.x  0.96
2013 Eiden RD, Homish GG, Colder CR, Schuetze P, Gray TR, Huestis MA. Changes in smoking patterns during pregnancy. Substance Use & Misuse. 48: 513-22. PMID 23581507 DOI: 10.3109/10826084.2013.787091  0.96
2013 Zanotti-Fregonara P, Hirvonen J, Lyoo CH, Zoghbi SS, Rallis-Frutos D, Huestis MA, Morse C, Pike VW, Innis RB. Population-based input function modeling for [(18)F]FMPEP-d 2, an inverse agonist radioligand for cannabinoid CB1 receptors: validation in clinical studies. Plos One. 8: e60231. PMID 23577094 DOI: 10.1371/journal.pone.0060231  0.96
2013 Muniyappa R, Sable S, Ouwerkerk R, Mari A, Gharib AM, Walter M, Courville A, Hall G, Chen KY, Volkow ND, Kunos G, Huestis MA, Skarulis MC. Metabolic effects of chronic cannabis smoking. Diabetes Care. 36: 2415-22. PMID 23530011 DOI: 10.2337/dc12-2303  0.96
2013 Scheidweiler KB, Schwope DM, Karschner EL, Desrosiers NA, Gorelick DA, Huestis MA. In vitro stability of free and glucuronidated cannabinoids in blood and plasma following controlled smoked cannabis. Clinical Chemistry. 59: 1108-17. PMID 23519966 DOI: 10.1373/clinchem.2012.201467  0.96
2013 Bergamaschi MM, Barnes A, Queiroz RH, Hurd YL, Huestis MA. Impact of enzymatic and alkaline hydrolysis on CBD concentration in urine. Analytical and Bioanalytical Chemistry. 405: 4679-89. PMID 23494274 DOI: 10.1007/s00216-013-6837-x  0.96
2013 Kirlic N, Newman E, Lagasse LL, Derauf C, Shah R, Smith LM, Arria AM, Huestis MA, Haning W, Strauss A, Dellagrotta S, Dansereau LM, Abar B, Neal CR, Lester BM. Cortisol reactivity in two-year-old children prenatally exposed to methamphetamine. Journal of Studies On Alcohol and Drugs. 74: 447-51. PMID 23490574  0.96
2013 Desrosiers NA, Barnes AJ, Hartman RL, Scheidweiler KB, Kolbrich-Spargo EA, Gorelick DA, Goodwin RS, Huestis MA. Oral fluid and plasma 3,4-methylenedioxymethamphetamine (MDMA) and metabolite correlation after controlled oral MDMA administration. Analytical and Bioanalytical Chemistry. 405: 4067-76. PMID 23471370 DOI: 10.1007/s00216-013-6848-7  0.96
2013 Wohlfarth A, Scheidweiler KB, Chen X, Liu HF, Huestis MA. Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC-MS/MS and library search. Analytical Chemistry. 85: 3730-8. PMID 23458260 DOI: 10.1021/ac3037365  0.96
2013 Bergamaschi MM, Karschner EL, Goodwin RS, Scheidweiler KB, Hirvonen J, Queiroz RH, Huestis MA. Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers' blood on per se drugged driving laws. Clinical Chemistry. 59: 519-26. PMID 23449702 DOI: 10.1373/clinchem.2012.195503  0.56
2013 Twomey J, LaGasse L, Derauf C, Newman E, Shah R, Smith L, Arria A, Huestis M, DellaGrotta S, Roberts M, Dansereau L, Neal C, Lester B. Prenatal methamphetamine exposure, home environment, and primary caregiver risk factors predict child behavioral problems at 5 years. The American Journal of Orthopsychiatry. 83: 64-72. PMID 23330624 DOI: 10.1111/ajop.12007  0.96
2013 Bosker WM, Karschner EL, Lee D, Goodwin RS, Hirvonen J, Innis RB, Theunissen EL, Kuypers KP, Huestis MA, Ramaekers JG. Psychomotor function in chronic daily Cannabis smokers during sustained abstinence. Plos One. 8: e53127. PMID 23301031 DOI: 10.1371/journal.pone.0053127  0.96
2013 Warren KR, Buchanan RW, Feldman S, Conley RR, Linthicum J, Ball MP, Liu F, McMahon RP, Gorelick DA, Huestis MA, Kelly DL. Effects of the cannabinoid-1 receptor antagonist/inverse agonist rimonabant on satiety signaling in overweight people with schizophrenia: a randomized, double-blind, pilot study. Journal of Clinical Psychopharmacology. 33: 118-20. PMID 23277241 DOI: 10.1097/JCP.0b013e3182793843  0.96
2013 Kiblawi ZN, Smith LM, LaGasse LL, Derauf C, Newman E, Shah R, Arria A, Huestis M, DellaGrotta S, Dansereau LM, Neal C, Lester B. The effect of prenatal methamphetamine exposure on attention as assessed by continuous performance tests: results from the Infant Development, Environment, and Lifestyle study. Journal of Developmental and Behavioral Pediatrics : Jdbp. 34: 31-7. PMID 23275056 DOI: 10.1097/DBP.0b013e318277a1c5  0.96
2013 Himes SK, Scheidweiler KB, Tassiopoulos K, Kacanek D, Hazra R, Rich K, Huestis MA. Development and validation of the first liquid chromatography-tandem mass spectrometry assay for simultaneous quantification of multiple antiretrovirals in meconium. Analytical Chemistry. 85: 1896-904. PMID 23256731 DOI: 10.1021/ac303188j  0.96
2013 Huestis MA, Cone EJ, Pirnay SO, Umbricht A, Preston KL. Intravenous buprenorphine and norbuprenorphine pharmacokinetics in humans Drug and Alcohol Dependence. 131: 258-262. PMID 23246635 DOI: 10.1016/j.drugalcdep.2012.11.014  0.96
2013 Hartman RL, Huestis MA. Cannabis effects on driving skills. Clinical Chemistry. 59: 478-92. PMID 23220273 DOI: 10.1373/clinchem.2012.194381  0.96
2013 Himes SK, Stroud LR, Scheidweiler KB, Niaura RS, Huestis MA. Prenatal tobacco exposure, biomarkers for tobacco in meconium, and neonatal growth outcomes. The Journal of Pediatrics. 162: 970-5. PMID 23211926 DOI: 10.1016/j.jpeds.2012.10.045  0.96
2013 Lee D, Karschner EL, Milman G, Barnes AJ, Goodwin RS, Huestis MA. Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration? Drug and Alcohol Dependence. 130: 68-76. PMID 23146820 DOI: 10.1016/j.drugalcdep.2012.10.011  0.96
2013 Gorelick DA, Goodwin RS, Schwilke E, Schwope DM, Darwin WD, Kelly DL, McMahon RP, Liu F, Ortemann-Renon C, Bonnet D, Huestis MA. Tolerance to effects of high-dose oral δ9-tetrahydrocannabinol and plasma cannabinoid concentrations in male daily cannabis smokers. Journal of Analytical Toxicology. 37: 11-6. PMID 23074216 DOI: 10.1093/jat/bks081  0.96
2013 Abar B, LaGasse LL, Derauf C, Newman E, Shah R, Smith LM, Arria A, Huestis M, Della Grotta S, Dansereau LM, Neal C, Lester BM. Examining the relationships between prenatal methamphetamine exposure, early adversity, and child neurobehavioral disinhibition. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 27: 662-73. PMID 23067308 DOI: 10.1037/a0030157  0.96
2013 Rose EJ, Ross TJ, Salmeron BJ, Lee M, Shakleya DM, Huestis MA, Stein EA. Acute nicotine differentially impacts anticipatory valence- and magnitude-related striatal activity. Biological Psychiatry. 73: 280-8. PMID 22939991 DOI: 10.1016/j.biopsych.2012.06.034  0.96
2013 Vandrey R, Stitzer ML, Mintzer MZ, Huestis MA, Murray JA, Lee D. The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users. Drug and Alcohol Dependence. 128: 64-70. PMID 22921474 DOI: 10.1016/j.drugalcdep.2012.08.001  0.96
2013 Wouldes TA, LaGasse LL, Derauf C, Newman E, Shah R, Smith LM, Arria AM, Huestis MA, DellaGrotta S, Wilcox T, Neal CR, Lester BM. Co-morbidity of substance use disorder and psychopathology in women who use methamphetamine during pregnancy in the US and New Zealand. Drug and Alcohol Dependence. 127: 101-7. PMID 22789630 DOI: 10.1016/j.drugalcdep.2012.06.016  0.96
2012 Desrosiers NA, Lee D, Schwope DM, Milman G, Barnes AJ, Gorelick DA, Huestis MA. On-site test for cannabinoids in oral fluid. Clinical Chemistry. 58: 1418-25. PMID 22912396 DOI: 10.1373/clinchem.2012.189001  0.96
2012 Scheidweiler KB, Desrosiers NA, Huestis MA. Simultaneous quantification of free and glucuronidated cannabinoids in human urine by liquid chromatography tandem mass spectrometry. Clinica Chimica Acta; International Journal of Clinical Chemistry. 413: 1839-47. PMID 22771478 DOI: 10.1016/j.cca.2012.06.034  0.96
2012 Haymond S, Saenger AK, Free HM, Hicks JM, Huestis MA, Horvath AR, Fantz CR. Altering the landscape for women in clinical chemistry: Perspectives from multigenerational leaders Clinical Chemistry. 58: 1082-1085. PMID 22623746 DOI: 10.1373/clinchem.2011.174284  0.96
2012 Ropero-Miller JD, Huestis MA, Stout PR. Cocaine analytes in human hair: evaluation of concentration ratios in different cocaine sources, drug-user populations and surface-contaminated specimens. Journal of Analytical Toxicology. 36: 390-8. PMID 22593566 DOI: 10.1093/jat/bks050  0.96
2012 Schwope DM, Bosker WM, Ramaekers JG, Gorelick DA, Huestis MA. Psychomotor performance, subjective and physiological effects and whole blood Δ⁹-tetrahydrocannabinol concentrations in heavy, chronic cannabis smokers following acute smoked cannabis. Journal of Analytical Toxicology. 36: 405-12. PMID 22589524 DOI: 10.1093/jat/bks044  0.96
2012 Smith LM, Paz MS, LaGasse LL, Derauf C, Newman E, Shah R, Arria A, Huestis MA, Haning W, Strauss A, Della Grotta S, Dansereau LM, Neal C, Lester BM. Maternal depression and prenatal exposure to methamphetamine: neurodevelopmental findings from the infant development, environment, and lifestyle (ideal) study. Depression and Anxiety. 29: 515-22. PMID 22555777 DOI: 10.1002/da.21956  0.96
2012 Liles BD, Newman E, Lagasse LL, Derauf C, Shah R, Smith LM, Arria AM, Huestis MA, Haning W, Strauss A, Dellagrotta S, Dansereau LM, Neal C, Lester BM. Perceived child behavior problems, parenting stress, and maternal depressive symptoms among prenatal methamphetamine users. Child Psychiatry and Human Development. 43: 943-57. PMID 22552952 DOI: 10.1007/s10578-012-0305-2  0.96
2012 Polettini A, Cone EJ, Gorelick DA, Huestis MA. Incorporation of methamphetamine and amphetamine in human hair following controlled oral methamphetamine administration. Analytica Chimica Acta. 726: 35-43. PMID 22541011 DOI: 10.1016/j.aca.2012.01.042  0.96
2012 Lee D, Milman G, Schwope DM, Barnes AJ, Gorelick DA, Huestis MA. Cannabinoid stability in authentic oral fluid after controlled cannabis smoking. Clinical Chemistry. 58: 1101-9. PMID 22532594 DOI: 10.1373/clinchem.2012.184929  0.96
2012 Himes SK, Goodwin RS, Rock CM, Jones HE, Johnson RE, Wilkins DG, Huestis MA. Methadone and metabolites in hair of methadone-assisted pregnant women and their infants Therapeutic Drug Monitoring. 34: 337-344. PMID 22495425 DOI: 10.1097/FTD.0b013e3182512b26  0.96
2012 Karschner EL, Schwope DM, Schwilke EW, Goodwin RS, Kelly DL, Gorelick DA, Huestis MA. Predictive model accuracy in estimating last Δ9-tetrahydrocannabinol (THC) intake from plasma and whole blood cannabinoid concentrations in chronic, daily cannabis smokers administered subchronic oral THC. Drug and Alcohol Dependence. 125: 313-9. PMID 22464363 DOI: 10.1016/j.drugalcdep.2012.03.005  0.96
2012 LaGasse LL, Derauf C, Smith LM, Newman E, Shah R, Neal C, Arria A, Huestis MA, DellaGrotta S, Lin H, Dansereau LM, Lester BM. Prenatal methamphetamine exposure and childhood behavior problems at 3 and 5 years of age. Pediatrics. 129: 681-8. PMID 22430455 DOI: 10.1542/peds.2011-2209  0.96
2012 Derauf C, Lagasse LL, Smith LM, Newman E, Shah R, Neal CR, Arria AM, Huestis MA, Dellagrotta S, Dansereau LM, Lin H, Lester BM. Prenatal methamphetamine exposure and inhibitory control among young school-age children. The Journal of Pediatrics. 161: 452-9. PMID 22424953 DOI: 10.1016/j.jpeds.2012.02.002  0.96
2012 Shah R, Diaz SD, Arria A, LaGasse LL, Derauf C, Newman E, Smith LM, Huestis MA, Haning W, Strauss A, Della Grotta S, Dansereau LM, Roberts MB, Neal C, Lester BM. Prenatal methamphetamine exposure and short-term maternal and infant medical outcomes. American Journal of Perinatology. 29: 391-400. PMID 22399214 DOI: 10.1055/s-0032-1304818  0.96
2012 Scheidweiler KB, Shakleya DM, Huestis MA. Simultaneous quantification of nicotine, cotinine, trans-3'-hydroxycotinine, norcotinine and mecamylamine in human urine by liquid chromatography-tandem mass spectrometry. Clinica Chimica Acta; International Journal of Clinical Chemistry. 413: 978-84. PMID 22394455 DOI: 10.1016/j.cca.2012.02.017  0.96
2012 Milman G, Schwope DM, Gorelick DA, Huestis MA. Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis. Clinica Chimica Acta; International Journal of Clinical Chemistry. 413: 765-70. PMID 22285315 DOI: 10.1016/j.cca.2012.01.011  0.96
2012 Lee D, Schwope DM, Milman G, Barnes AJ, Gorelick DA, Huestis MA. Cannabinoid disposition in oral fluid after controlled smoked cannabis. Clinical Chemistry. 58: 748-56. PMID 22273566 DOI: 10.1373/clinchem.2011.177881  0.96
2012 Schwaninger AE, Meyer MR, Barnes AJ, Kolbrich-Spargo EA, Gorelick DA, Goodwin RS, Huestis MA, Maurer HH. Stereoselective urinary MDMA (ecstasy) and metabolites excretion kinetics following controlled MDMA administration to humans. Biochemical Pharmacology. 83: 131-8. PMID 21983032 DOI: 10.1016/j.bcp.2011.09.023  0.96
2012 Zabaneh R, Smith LM, LaGasse LL, Derauf C, Newman E, Shah R, Arria A, Huestis M, Haning W, Strauss A, Della Grotta S, Dansereau LM, Lin H, Neal C, Lester BM. The effects of prenatal methamphetamine exposure on childhood growth patterns from birth to 3 years of age. American Journal of Perinatology. 29: 203-10. PMID 21818727 DOI: 10.1055/s-0031-1285094  0.96
2012 Goodwin RS, Baumann MH, Gorelick DA, Schwilke E, Schwope DM, Darwin WD, Kelly DL, Schroeder JR, Ortemann-Renon C, Bonnet D, Huestis MA. CB1 - cannabinoid receptor antagonist effects on cortisol in cannabis-dependent men. The American Journal of Drug and Alcohol Abuse. 38: 114-9. PMID 21797816 DOI: 10.3109/00952990.2011.600398  0.96
2012 Donovan DM, Bigelow GE, Brigham GS, Carroll KM, Cohen AJ, Gardin JG, Hamilton JA, Huestis MA, Hughes JR, Lindblad R, Marlatt GA, Preston KL, Selzer JA, Somoza EC, Wakim PG, et al. Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials. Addiction (Abingdon, England). 107: 694-708. PMID 21781202 DOI: 10.1111/j.1360-0443.2011.03473.x  0.96
2012 Hirvonen J, Goodwin RS, Li CT, Terry GE, Zoghbi SS, Morse C, Pike VW, Volkow ND, Huestis MA, Innis RB. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Molecular Psychiatry. 17: 642-9. PMID 21747398 DOI: 10.1038/mp.2011.82  0.96
2012 Srijanto BR, Cheney CP, Hedden DL, Gehl AC, Crilly PB, Huestis MA, Ferrell TL. Piezoresistive microcantilevers-based cocaine biosensors Sensor Letters. 10: 850-855. DOI: 10.1166/sl.2012.2335  0.96
2011 Eiden RD, Leonard KE, Colder CR, Homish GG, Schuetze P, Gray TR, Huestis MA. Anger, hostility, and aggression as predictors of persistent smoking during pregnancy. Journal of Studies On Alcohol and Drugs. 72: 926-32. PMID 22051206  0.96
2011 Huestis MA, Mazzoni I, Rabin O. Cannabis in sport: Anti-doping perspective Sports Medicine. 41: 949-966. PMID 21985215 DOI: 10.2165/11591430-000000000-00000  0.96
2011 Schwaninger AE, Meyer MR, Barnes AJ, Kolbrich-Spargo EA, Gorelick DA, Goodwin RS, Huestis MA, Maurer HH. Urinary excretion kinetics of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its phase I and phase II metabolites in humans following controlled MDMA administration. Clinical Chemistry. 57: 1748-56. PMID 21980168 DOI: 10.1373/clinchem.2011.172254  0.96
2011 Milman G, Schwope DM, Schwilke EW, Darwin WD, Kelly DL, Goodwin RS, Gorelick DA, Huestis MA. Oral fluid and plasma cannabinoid ratios after around-the-clock controlled oral Δ(9)-tetrahydrocannabinol administration. Clinical Chemistry. 57: 1597-606. PMID 21875944 DOI: 10.1373/clinchem.2011.169490  0.96
2011 Scheidweiler KB, Ladenheim B, Barnes AJ, Cadet JL, Huestis MA. (±)-3,4-methylenedioxymethamphetamine and metabolite disposition in plasma and striatum of wild-type and multidrug resistance protein 1a knock-out mice. Journal of Analytical Toxicology. 35: 470-80. PMID 21871156  0.96
2011 Gorelick DA, Goodwin RS, Schwilke E, Schwope DM, Darwin WD, Kelly DL, McMahon RP, Liu F, Ortemann-Renon C, Bonnet D, Huestis MA. Antagonist-elicited cannabis withdrawal in humans. Journal of Clinical Psychopharmacology. 31: 603-12. PMID 21869692 DOI: 10.1097/JCP.0b013e31822befc1  0.96
2011 Barnes AJ, Scheidweiler KB, Kolbrich-Spargo EA, Gorelick DA, Goodwin RS, Huestis MA. MDMA and metabolite disposition in expectorated oral fluid after controlled oral MDMA administration. Therapeutic Drug Monitoring. 33: 602-8. PMID 21860342 DOI: 10.1097/FTD.0b013e3182281975  0.96
2011 Scheidweiler KB, Marrone GF, Shakleya DM, Singleton EG, Heishman SJ, Huestis MA. Oral fluid nicotine markers to assess smoking status and recency of use. Therapeutic Drug Monitoring. 33: 609-18. PMID 21860341 DOI: 10.1097/FTD.0b013e318228ba39  0.96
2011 Concheiro M, Jones HE, Johnson RE, Choo R, Huestis MA. Preliminary buprenorphine sublingual tablet pharmacokinetic data in plasma, oral fluid, and sweat during treatment of opioid-dependent pregnant women Therapeutic Drug Monitoring. 33: 619-626. PMID 21860340 DOI: 10.1097/FTD.0b013e318228bb2a  0.96
2011 Schwope DM, Karschner EL, Gorelick DA, Huestis MA. Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration. Clinical Chemistry. 57: 1406-14. PMID 21836075 DOI: 10.1373/clinchem.2011.171777  0.96
2011 Schuetze P, Eiden RD, Colder CR, Gray TR, Huestis MA. Physiological regulation in cigarette exposed infants: an examination of potential moderators. Neurotoxicology and Teratology. 33: 567-74. PMID 21798345 DOI: 10.1016/j.ntt.2011.07.004  0.96
2011 Holland MG, Schwope DM, Stoppacher R, Gillen SB, Huestis MA. Postmortem redistribution of Δ9-tetrahydrocannabinol (THC), 11-hydroxy-THC (11-OH-THC), and 11-nor-9-carboxy-THC (THCCOOH). Forensic Science International. 212: 247-51. PMID 21764230 DOI: 10.1016/j.forsciint.2011.06.028  0.96
2011 de Castro A, Jones HE, Johnson RE, Gray TR, Shakleya DM, Huestis MA. Methadone, cocaine, opiates, and metabolite disposition in umbilical cord and correlations to maternal methadone dose and neonatal outcomes. Therapeutic Drug Monitoring. 33: 443-52. PMID 21743375 DOI: 10.1097/FTD.0b013e31822724f0  0.52
2011 Schwope DM, Scheidweiler KB, Huestis MA. Direct quantification of cannabinoids and cannabinoid glucuronides in whole blood by liquid chromatography-tandem mass spectrometry. Analytical and Bioanalytical Chemistry. 401: 1273-83. PMID 21727996 DOI: 10.1007/s00216-011-5197-7  0.96
2011 Lee D, Milman G, Barnes AJ, Goodwin RS, Hirvonen J, Huestis MA. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence. Clinical Chemistry. 57: 1127-36. PMID 21677094 DOI: 10.1373/clinchem.2011.164822  0.96
2011 Schwaninger AE, Meyer MR, Huestis MA, Maurer HH. Development and validation of LC-HRMS and GC-NICI-MS methods for stereoselective determination of MDMA and its phase i and II metabolites in human urine Journal of Mass Spectrometry. 46: 603-614. PMID 21656610 DOI: 10.1002/jms.1929  0.96
2011 Milman G, Barnes AJ, Schwope DM, Schwilke EW, Goodwin RS, Kelly DL, Gorelick DA, Huestis MA. Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-the-clock oral THC administration. Analytical and Bioanalytical Chemistry. 401: 599-607. PMID 21637933 DOI: 10.1007/s00216-011-5066-4  0.96
2011 Marrone GF, Shakleya DM, Scheidweiler KB, Singleton EG, Huestis MA, Heishman SJ. Relative performance of common biochemical indicators in detecting cigarette smoking. Addiction (Abingdon, England). 106: 1325-34. PMID 21438939 DOI: 10.1111/j.1360-0443.2011.03441.x  0.96
2011 Smith LM, LaGasse LL, Derauf C, Newman E, Shah R, Haning W, Arria A, Huestis M, Strauss A, Della Grotta S, Dansereau LM, Lin H, Lester BM. Motor and cognitive outcomes through three years of age in children exposed to prenatal methamphetamine. Neurotoxicology and Teratology. 33: 176-84. PMID 21256431 DOI: 10.1016/j.ntt.2010.10.004  0.96
2011 de Castro A, Jones HE, Johnson RE, Gray TR, Shakleya DM, Huestis MA. Maternal methadone dose, placental methadone concentrations, and neonatal outcomes. Clinical Chemistry. 57: 449-58. PMID 21245372 DOI: 10.1373/clinchem.2010.154864  0.52
2011 Derauf C, LaGasse L, Smith L, Newman E, Shah R, Arria A, Huestis M, Haning W, Strauss A, Della Grotta S, Dansereau L, Lin H, Lester B. Infant temperament and high-risk environment relate to behavior problems and language in toddlers. Journal of Developmental and Behavioral Pediatrics : Jdbp. 32: 125-35. PMID 21200329 DOI: 10.1097/DBP.0b013e31820839d7  0.96
2011 Kelly DL, Gorelick DA, Conley RR, Boggs DL, Linthicum J, Liu F, Feldman S, Ball MP, Wehring HJ, McMahon RP, Huestis MA, Heishman SJ, Warren KR, Buchanan RW. Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study. Journal of Clinical Psychopharmacology. 31: 86-91. PMID 21192149 DOI: 10.1097/JCP.0b013e318204825b  0.96
2011 Schwilke EW, Gullberg RG, Darwin WD, Chiang CN, Cadet JL, Gorelick DA, Pope HG, Huestis MA. Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users. Addiction (Abingdon, England). 106: 499-506. PMID 21134021 DOI: 10.1111/j.1360-0443.2010.03228.x  0.96
2011 Concheiro M, Shakleya DM, Huestis MA. Simultaneous analysis of buprenorphine, methadone, cocaine, opiates and nicotine metabolites in sweat by liquid chromatography tandem mass spectrometry Analytical and Bioanalytical Chemistry. 400: 69-78. PMID 21125263 DOI: 10.1007/s00216-010-4392-2  0.96
2011 Karschner EL, Darwin WD, Goodwin RS, Wright S, Huestis MA. Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration. Clinical Chemistry. 57: 66-75. PMID 21078841 DOI: 10.1373/clinchem.2010.152439  0.96
2011 Sutherland MT, Ross TJ, Shakleya DM, Huestis MA, Stein EA. Chronic smoking, but not acute nicotine administration, modulates neural correlates of working memory. Psychopharmacology. 213: 29-42. PMID 20862456 DOI: 10.1007/s00213-010-2013-6  0.96
2011 Gray TR, Dams R, Choo RE, Jones HE, Huestis MA. Methadone disposition in oral fluid during pharmacotherapy for opioid-dependence Forensic Science International. 206: 98-102. PMID 20667673 DOI: 10.1016/j.forsciint.2010.06.031  0.96
2011 LaGasse LL, Wouldes T, Newman E, Smith LM, Shah RZ, Derauf C, Huestis MA, Arria AM, Della Grotta S, Wilcox T, Lester BM. Prenatal methamphetamine exposure and neonatal neurobehavioral outcome in the USA and New Zealand. Neurotoxicology and Teratology. 33: 166-75. PMID 20615464 DOI: 10.1016/j.ntt.2010.06.009  0.96
2011 Delaney-Black V, Chiodo LM, Hannigan JH, Greenwald MK, Janisse J, Patterson G, Huestis MA, Partridge RT, Ager J, Sokol RJ. Prenatal and postnatal cocaine exposure predict teen cocaine use. Neurotoxicology and Teratology. 33: 110-9. PMID 20609384 DOI: 10.1016/j.ntt.2010.06.011  0.96
2010 Concheiro M, Jones HE, Johnson RE, Choo R, Shakleya DM, Huestis MA. Umbilical cord monitoring of in utero drug exposure to buprenorphine and correlation with maternal dose and neonatal outcomes Journal of Analytical Toxicology. 34: 498-505. PMID 21819795  0.96
2010 Delaney-Black V, Chiodo LM, Hannigan JH, Greenwald MK, Janisse J, Patterson G, Huestis MA, Ager J, Sokol RJ. Just say "I don't": lack of concordance between teen report and biological measures of drug use. Pediatrics. 126: 887-93. PMID 20974792 DOI: 10.1542/peds.2009-3059  0.96
2010 Gray TR, Choo RE, Concheiro M, Williams E, Elko A, Jansson LM, Jones HE, Huestis MA. Prenatal methadone exposure, meconium biomarker concentrations and neonatal abstinence syndrome. Addiction (Abingdon, England). 105: 2151-9. PMID 20854338 DOI: 10.1111/j.1360-0443.2010.03097.x  0.36
2010 Scheidweiler KB, Spargo EA, Kelly TL, Cone EJ, Barnes AJ, Huestis MA. Pharmacokinetics of cocaine and metabolites in human oral fluid and correlation with plasma concentrations after controlled administration. Therapeutic Drug Monitoring. 32: 628-37. PMID 20814350 DOI: 10.1097/FTD.0b013e3181f2b729  0.96
2010 Copersino ML, Boyd SJ, Tashkin DP, Huestis MA, Heishman SJ, Dermand JC, Simmons MS, Gorelick DA. Sociodemographic characteristics of cannabis smokers and the experience of cannabis withdrawal. The American Journal of Drug and Alcohol Abuse. 36: 311-9. PMID 20678028 DOI: 10.3109/00952990.2010.503825  0.96
2010 Concheiro M, Gray TR, Shakleya DM, Huestis MA. High-throughput simultaneous analysis of buprenorphine, methadone, cocaine, opiates, nicotine, and metabolites in oral fluid by liquid chromatography tandem mass spectrometry Analytical and Bioanalytical Chemistry. 398: 915-924. PMID 20652688 DOI: 10.1007/s00216-010-3903-5  0.96
2010 Nguyen D, Smith LM, Lagasse LL, Derauf C, Grant P, Shah R, Arria A, Huestis MA, Haning W, Strauss A, Della Grotta S, Liu J, Lester BM. Intrauterine growth of infants exposed to prenatal methamphetamine: results from the infant development, environment, and lifestyle study. The Journal of Pediatrics. 157: 337-9. PMID 20570284 DOI: 10.1016/j.jpeds.2010.04.024  0.96
2010 Milman G, Barnes AJ, Schwope DM, Schwilke EW, Darwin WD, Goodwin RS, Kelly DL, Gorelick DA, Huestis MA. Disposition of cannabinoids in oral fluid after controlled around-the-clock oral THC administration. Clinical Chemistry. 56: 1261-9. PMID 20530732 DOI: 10.1373/clinchem.2009.141853  0.96
2010 Gray TR, Barnes AJ, Huestis MA. Effect of hydrolysis on identifying prenatal cannabis exposure Analytical and Bioanalytical Chemistry. 397: 2335-2347. PMID 20517601 DOI: 10.1007/s00216-010-3772-y  0.96
2010 Schwope DM, Milman G, Huestis MA. Validation of an enzyme immunoassay for detection and semiquantification of cannabinoids in oral fluid. Clinical Chemistry. 56: 1007-14. PMID 20360126 DOI: 10.1373/clinchem.2009.141754  0.96
2010 Karschner EL, Barnes AJ, Lowe RH, Scheidweiler KB, Huestis MA. Validation of a two-dimensional gas chromatography mass spectrometry method for the simultaneous quantification of cannabidiol, Delta(9)-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC in plasma. Analytical and Bioanalytical Chemistry. 397: 603-11. PMID 20306180 DOI: 10.1007/s00216-010-3599-6  0.96
2010 Smith ML, Shimomura E, Paul BD, Cone EJ, Darwin WD, Huestis MA. Urinary excretion of ecgonine and five other cocaine metabolites following controlled oral, intravenous, intranasal, and smoked administration of cocaine. Journal of Analytical Toxicology. 34: 57-63. PMID 20223096 DOI: 10.1093/JAT/34.2.57  0.96
2010 Concheiro M, Jones HE, Johnson RE, Choo R, Shakleya DM, Huestis MA. Maternal buprenorphine dose, placenta buprenorphine, and metabolite concentrations and neonatal outcomes Therapeutic Drug Monitoring. 32: 206-215. PMID 20216119 DOI: 10.1097/FTD.0b013e3181d0bd68  0.96
2010 Gray TR, Kelly T, LaGasse LL, Smith LM, Derauf C, Grant P, Shah R, Arria A, Haning W, Della Grotta S, Strauss A, Lester BM, Huestis MA. New meconium biomarkers of prenatal methamphetamine exposure increase identification of affected neonates. Clinical Chemistry. 56: 856-60. PMID 20185623 DOI: 10.1373/clinchem.2009.139055  0.96
2010 Shakleya DM, Dams R, Choo RE, Hendree J, Huestis MA. Simultaneous liquid chromatography-mass spectrometry quantification of urinary opiates, cocaine, and metabolites in opiate-dependent pregnantwomen in methadone-maintenance treatment Journal of Analytical Toxicology. 34: 17-25. PMID 20109298  0.96
2010 Milman G, Barnes AJ, Lowe RH, Huestis MA. Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry Journal of Chromatography A. 1217: 1513-1521. PMID 20083251 DOI: 10.1016/j.chroma.2009.12.053  0.96
2010 Scheidweiler KB, Ladenheim B, Cadet JL, Huestis MA. Mice lacking multidrug resistance protein 1a show altered dopaminergic responses to methylenedioxymethamphetamine (MDMA) in striatum. Neurotoxicity Research. 18: 200-9. PMID 19851718 DOI: 10.1007/s12640-009-9124-z  0.96
2010 Della Grotta S, LaGasse LL, Arria AM, Derauf C, Grant P, Smith LM, Shah R, Huestis M, Liu J, Lester BM. Patterns of methamphetamine use during pregnancy: results from the Infant Development, Environment, and Lifestyle (IDEAL) Study. Maternal and Child Health Journal. 14: 519-27. PMID 19565330 DOI: 10.1007/s10995-009-0491-0  0.96
2009 Westin AA, Huestis MA, Aarstad K, Spigset O. Urinary excretion of 11-nor-9-carboxy-Δ9- tetrahydrocannabinol in a pregnant woman following heavy, chronic cannabis use Journal of Analytical Toxicology. 33: 610-614. PMID 20040136  0.96
2009 Concheiro M, Jones H, Johnson RE, Shakleya DM, Huestis MA. Confirmatory analysis of buprenorphine, norbuprenorphine, and glucuronide metabolites in plasma by LCMSMS. Application to umbilical cord plasma from buprenorphine-maintained pregnant women Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 878: 13-20. PMID 19945361 DOI: 10.1016/j.jchromb.2009.11.005  0.96
2009 Karschner EL, Schwilke EW, Lowe RH, Darwin WD, Herning RI, Cadet JL, Huestis MA. Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers. Journal of Analytical Toxicology. 33: 469-77. PMID 19874654 DOI: 10.1093/jat/33.8.469  0.64
2009 Abraham TT, Barnes AJ, Lowe RH, Kolbrich Spargo EA, Milman G, Pirnay SO, Gorelick DA, Goodwin RS, Huestis MA. Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humans. Journal of Analytical Toxicology. 33: 439-46. PMID 19874650 DOI: 10.1093/JAT/33.8.439  0.96
2009 Shakleya DM, Huestis MA. Optimization and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of nicotine, cotinine, trans-3′-hydroxycotinine and norcotinine in human oral fluid Analytical and Bioanalytical Chemistry. 395: 2349-2357. PMID 19838828 DOI: 10.1007/s00216-009-3157-2  0.96
2009 Schwilke EW, Schwope DM, Karschner EL, Lowe RH, Darwin WD, Kelly DL, Goodwin RS, Gorelick DA, Huestis MA. Delta9-tetrahydrocannabinol (THC), 11-hydroxy-THC, and 11-nor-9-carboxy-THC plasma pharmacokinetics during and after continuous high-dose oral THC. Clinical Chemistry. 55: 2180-9. PMID 19833841 DOI: 10.1373/clinchem.2008.122119  0.96
2009 Huestis MA. A new ultraperformance - Tandem mass spectrometry oral fluid assay for 29 illicit drugs and medications Clinical Chemistry. 55: 2079-2081. PMID 19833833 DOI: 10.1373/clinchem.2009.134551  0.96
2009 Karschner EL, Schwilke EW, Lowe RH, Darwin WD, Pope HG, Herning R, Cadet JL, Huestis MA. Do Delta9-tetrahydrocannabinol concentrations indicate recent use in chronic cannabis users? Addiction (Abingdon, England). 104: 2041-8. PMID 19804462 DOI: 10.1111/j.1360-0443.2009.02705.x  0.96
2009 Shakleya DM, Huestis MA. Simultaneous and sensitive measurement of nicotine, cotinine, trans-3′-hydroxycotinine and norcotinine in human plasma by liquid chromatography-tandem mass spectrometry Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 877: 3537-3542. PMID 19748838 DOI: 10.1016/j.jchromb.2009.08.033  0.96
2009 Bosker WM, Huestis MA. Oral fluid testing for drugs of abuse Clinical Chemistry. 55: 1910-1931. PMID 19745062 DOI: 10.1373/clinchem.2008.108670  0.96
2009 Baumann MH, Zolkowska D, Kim I, Scheidweiler KB, Rothman RB, Huestis MA. Effects of dose and route of administration on pharmacokinetics of (+ or -)-3,4-methylenedioxymethamphetamine in the rat. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 37: 2163-70. PMID 19679675 DOI: 10.1124/dmd.109.028506  0.96
2009 De Castro A, Concheiro M, Shakleya DM, Huestis MA. Simultaneous quantification of methadone, cocaine, opiates, and metabolites in human placenta by liquid chromatography-mass spectrometry Journal of Analytical Toxicology. 33: 243-252. PMID 19671243  0.96
2009 de Castro A, Concheiro M, Shakleya DM, Huestis MA. Development and validation of a liquid chromatography mass spectrometry assay for the simultaneous quantification of methadone, cocaine, opiates and metabolites in human umbilical cord Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 877: 3065-3071. PMID 19656745 DOI: 10.1016/j.jchromb.2009.07.028  0.96
2009 Lowe RH, Abraham TT, Darwin WD, Herning R, Cadet JL, Huestis MA. Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure. Drug and Alcohol Dependence. 105: 24-32. PMID 19631478 DOI: 10.1016/j.drugalcdep.2009.05.027  0.64
2009 Smith ML, Barnes AJ, Huestis MA. Identifying new cannabis use with urine creatinine-normalized THCCOOH concentrations and time intervals between specimen collections. Journal of Analytical Toxicology. 33: 185-9. PMID 19470219  0.96
2009 Mueller M, Kolbrich EA, Peters FT, Maurer HH, McCann UD, Huestis MA, Ricaurte GA. Direct comparison of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") disposition and metabolism in squirrel monkeys and humans. Therapeutic Drug Monitoring. 31: 367-73. PMID 19417716 DOI: 10.1097/FTD.0b013e3181a4f6c2  0.96
2009 Concheiro M, Shakleya DM, Huestis MA. Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine-glucuronide and norbuprenorphine-glucuronide in human umbilical cord by liquid chromatography tandem mass spectrometry Forensic Science International. 188: 144-151. PMID 19406593 DOI: 10.1016/j.forsciint.2009.04.005  0.96
2009 Kacinko SL, Jones HE, Johnson RE, Choo RE, Concheiro-Guisan M, Huestis MA. Urinary excretion of buprenorphine, norbuprenorphine, buprenorphine-glucuronide, and norbuprenorphine-glucuronide in pregnant women receiving buprenorphine maintenance treatment. Clinical Chemistry. 55: 1177-87. PMID 19325013 DOI: 10.1373/clinchem.2008.113712  0.96
2009 Schwilke EW, Karschner EL, Lowe RH, Gordon AM, Cadet JL, Herning RI, Huestis MA. Intra- and intersubject whole blood/plasma cannabinoid ratios determined by 2-dimensional, electron impact GC-MS with cryofocusing. Clinical Chemistry. 55: 1188-95. PMID 19264857 DOI: 10.1373/clinchem.2008.114405  0.96
2009 Concheiro-Guisan M, Shakleya DM, Huestis MA. Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in human placenta by liquid chromatography mass spectrometry Analytical and Bioanalytical Chemistry. 394: 513-522. PMID 19247639 DOI: 10.1007/s00216-009-2706-z  0.96
2009 Gray TR, Shakleya DM, Huestis MA. A liquid chromatography tandem mass spectrometry method for the simultaneous quantification of 20 drugs of abuse and metabolites in human meconium Analytical and Bioanalytical Chemistry. 393: 1977-1990. PMID 19241063 DOI: 10.1007/s00216-009-2680-5  0.96
2009 Shakleya DM, Huestis MA. Simultaneous quantification of nicotine, opioids, cocaine, and metabolites in human fetal postmortem brain by liquid chromatography tandem mass spectrometry Analytical and Bioanalytical Chemistry. 393: 1957-1965. PMID 19229524 DOI: 10.1007/s00216-009-2661-8  0.96
2009 Mueller M, Kolbrich-Spargo EA, Peters FT, Huestis MA, Ricaurte GA, Maurer HH. Hydrolysis of 3,4-methylenedioxymethamphetamine (MDMA) metabolite conjugates in human, squirrel monkey, and rat plasma. Analytical and Bioanalytical Chemistry. 393: 1607-17. PMID 19183967 DOI: 10.1007/s00216-009-2607-1  0.96
2009 Barnes AJ, De Martinis BS, Gorelick DA, Goodwin RS, Kolbrich EA, Huestis MA. Disposition of MDMA and metabolites in human sweat following controlled MDMA administration. Clinical Chemistry. 55: 454-62. PMID 19168553 DOI: 10.1373/clinchem.2008.117093  0.96
2009 Mueller M, Peters FT, Huestis MA, Ricaurte GA, Maurer HH. Simultaneous liquid chromatographic-electrospray ionization mass spectrometric quantification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its metabolites 3,4-dihydroxymethamphetamine, 4-hydroxy-3-methoxymethamphetamine and 3,4-methylenedioxyamphetamine in squirrel monkey and human plasma after acidic conjugate cleavage. Forensic Science International. 184: 64-8. PMID 19131196 DOI: 10.1016/j.forsciint.2008.12.002  0.96
2009 Hahn B, Ross TJ, Wolkenberg FA, Shakleya DM, Huestis MA, Stein EA. Performance effects of nicotine during selective attention, divided attention, and simple stimulus detection: an fMRI study. Cerebral Cortex (New York, N.Y. : 1991). 19: 1990-2000. PMID 19073624 DOI: 10.1093/cercor/bhn226  0.96
2009 Huestis MA, Smith ML. Pharmacokinetics and pharmacodynamics of drugs abused in driving Drugs, Driving and Traffic Safety. 151-185. DOI: 10.1007/978-3-7643-9923-8_11  0.96
2008 Elkashef A, Vocci F, Huestis M, Haney M, Budney A, Gruber A, el-Guebaly N. Marijuana neurobiology and treatment. Substance Abuse. 29: 17-29. PMID 19042204 DOI: 10.1080/08897070802218166  0.96
2008 Scheidweiler KB, Barnes AJ, Huestis MA. A validated gas chromatographic-electron impact ionization mass spectrometric method for methamphetamine, methylenedioxymethamphetamine (MDMA), and metabolites in mouse plasma and brain. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 876: 266-76. PMID 19026602 DOI: 10.1016/j.jchromb.2008.11.001  0.96
2008 Walsh JM, Verstraete AG, Huestis MA, Mørland J. Guidelines for research on drugged driving Addiction. 103: 1258-1268. PMID 18855814 DOI: 10.1111/j.1360-0443.2008.02277.x  0.96
2008 Kanneganti P, Huestis MA, Kolbrich EA, Goodwin R, Ziegelstein RC, Gorelick DA. Signal-averaged electrocardiogram in physically healthy, chronic 3,4-methylenedioxymethamphetamine (MDMA) users. The American Journal of Drug and Alcohol Abuse. 34: 712-20. PMID 18855243 DOI: 10.1080/00952990802308254  0.96
2008 Gray TR, Magri R, Shakleya DM, Huestis MA. Meconium nicotine and metabolites by liquid chromatography-tandem mass spectrometry: Differentiation of passive and nonexposure and correlation with neonatal outcome measures Clinical Chemistry. 54: 2018-2027. PMID 18845770 DOI: 10.1373/clinchem.2008.109173  0.96
2008 Kacinko SL, Concheiro-Guisan M, Shakleya DM, Huestis MA. Development and validation of a liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of buprenorphine, norbuprenorphine, and metabolites in human urine. Analytical and Bioanalytical Chemistry. 392: 903-11. PMID 18758763 DOI: 10.1007/s00216-008-2326-z  0.96
2008 Kacinko SL, Jones HE, Johnson RE, Choo RE, Huestis MA. Correlations of maternal buprenorphine dose, buprenorphine, and metabolite concentrations in meconium with neonatal outcomes. Clinical Pharmacology and Therapeutics. 84: 604-12. PMID 18701886 DOI: 10.1038/clpt.2008.156  0.96
2008 Kolbrich EA, Goodwin RS, Gorelick DA, Hayes RJ, Stein EA, Huestis MA. Physiological and subjective responses to controlled oral 3,4-methylenedioxymethamphetamine administration. Journal of Clinical Psychopharmacology. 28: 432-40. PMID 18626271 DOI: 10.1097/JCP.0b013e31817ef470  0.96
2008 Brunet BR, Barnes AJ, Scheidweiler KB, Mura P, Huestis MA. Development and validation of a solid-phase extraction gas chromatography-mass spectrometry method for the simultaneous quantification of methadone, heroin, cocaine and metabolites in sweat. Analytical and Bioanalytical Chemistry. 392: 115-27. PMID 18607576 DOI: 10.1007/s00216-008-2228-0  0.96
2008 Lee CT, Chen J, Hayashi T, Tsai SY, Sanchez JF, Errico SL, Amable R, Su TP, Lowe RH, Huestis MA, Shen J, Becker KG, Geller HM, Freed WJ. A mechanism for the inhibition of neural progenitor cell proliferation by cocaine. Plos Medicine. 5: e117. PMID 18593214 DOI: 10.1371/journal.pmed.0050117  0.96
2008 Kolbrich EA, Goodwin RS, Gorelick DA, Hayes RJ, Stein EA, Huestis MA. Plasma pharmacokinetics of 3,4-methylenedioxymethamphetamine after controlled oral administration to young adults. Therapeutic Drug Monitoring. 30: 320-32. PMID 18520604 DOI: 10.1097/FTD.0b013e3181684fa0  0.96
2008 Kelly T, Gray TR, Huestis MA. Development and validation of a liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry method for simultaneous analysis of 10 amphetamine-, methamphetamine- and 3,4-methylenedioxymethamphetamine-related (MDMA) analytes in human meconium Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 867: 194-204. PMID 18424195 DOI: 10.1016/j.jchromb.2008.03.029  0.96
2008 Jansson LM, Choo R, Velez ML, Lowe R, Huestis MA. Methadone maintenance and long-term lactation. Breastfeeding Medicine : the Official Journal of the Academy of Breastfeeding Medicine. 3: 34-7. PMID 18333767 DOI: 10.1089/bfm.2007.0032  0.96
2008 Gray TR, Shakleya DM, Huestis MA. Quantification of nicotine, cotinine, trans-3′-hydroxycotinine, nornicotine and norcotinine in human meconium by liquid chromatography/tandem mass spectrometry Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 863: 107-114. PMID 18243821 DOI: 10.1016/j.jchromb.2008.01.001  0.96
2008 Jansson LM, Choo R, Velez ML, Harrow C, Schroeder JR, Shakleya DM, Huestis MA. Methadone maintenance and breastfeeding in the neonatal period. Pediatrics. 121: 106-14. PMID 18166563 DOI: 10.1542/peds.2007-1182  0.52
2008 Kolbrich EA, Lowe RH, Huestis MA. Two-dimensional gas chromatography/electron-impact mass spectrometry with cryofocusing for simultaneous quantification of MDMA, MDA, HMMA, HMA, and MDEA in human plasma. Clinical Chemistry. 54: 379-87. PMID 18089653 DOI: 10.1373/clinchem.2007.096800  0.96
2008 Kacinko SL, Shakleya DM, Huestis MA. Validation and application of a method for the determination of buprenorphine, norbuprenorphine, and their glucuronide conjugates in human meconium. Analytical Chemistry. 80: 246-52. PMID 18044957 DOI: 10.1021/ac701627q  0.96
2008 Barnes AJ, Smith ML, Kacinko SL, Schwilke EW, Cone EJ, Moolchan ET, Huestis MA. Excretion of methamphetamine and amphetamine in human sweat following controlled oral methamphetamine administration. Clinical Chemistry. 54: 172-80. PMID 17981924 DOI: 10.1373/clinchem.2007.092304  0.96
2008 Huestis MA, Scheidweiler KB, Saito T, Fortner N, Abraham T, Gustafson RA, Smith ML. Excretion of Delta9-tetrahydrocannabinol in sweat. Forensic Science International. 174: 173-7. PMID 17481836 DOI: 10.1016/j.forsciint.2007.04.002  0.96
2007 Abraham TT, Lowe RH, Pirnay SO, Darwin WD, Huestis MA. Simultaneous GC-EI-MS determination of Δ9- tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol, and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in human urine following tandem enzyme-alkaline hydrolysis Journal of Analytical Toxicology. 31: 477-485. PMID 17988462  0.96
2007 Huestis MA, Darwin WD, Shimomura E, Lalani SA, Trinidad DV, Jenkins AJ, Cone EJ, Jacobs AJ, Smith ML, Paul BD. Cocaine and metabolites urinary excretion after controlled smoked administration. Journal of Analytical Toxicology. 31: 462-8. PMID 17988460 DOI: 10.1093/JAT/31.8.462  0.96
2007 Goodwin RS, Wilkins DG, Averin O, Choo RE, Schroeder JR, Jasinski DR, Johnson RE, Jones HE, Huestis MA. Buprenorphine and norbuprenorphine in hair of pregnant women and their infants after controlled buprenorphine administration. Clinical Chemistry. 53: 2136-43. PMID 17921260 DOI: 10.1373/clinchem.2007.091413  0.44
2007 Huestis MA. Human cannabinoid pharmacokinetics Chemistry and Biodiversity. 4: 1770-1804. PMID 17712819 DOI: 10.1002/cbdv.200790152  0.96
2007 Lowe RH, Karschner EL, Schwilke EW, Barnes AJ, Huestis MA. Simultaneous quantification of Delta9-tetrahydrocannabinol, 11-hydroxy-Delta9-tetrahydrocannabinol, and 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometry. Journal of Chromatography. A. 1163: 318-27. PMID 17640656 DOI: 10.1016/j.chroma.2007.06.069  0.96
2007 Huestis MA, Boyd SJ, Heishman SJ, Preston KL, Bonnet D, Le Fur G, Gorelick DA. Single and multiple doses of rimonabant antagonize acute effects of smoked cannabis in male cannabis users. Psychopharmacology. 194: 505-15. PMID 17619859 DOI: 10.1007/s00213-007-0861-5  0.96
2007 Shakleya DM, Jansson LM, Huestis MA. Validation of a LC-APCI-MS/MS method for quantification of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) and 2-ethyl-5-methyl-3,3-diphenylpyraline (EMDP) in infant plasma following protein precipitation Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 856: 267-272. PMID 17602899 DOI: 10.1016/j.jchromb.2007.06.004  0.96
2007 Choo RE, Jansson LM, Scheidweiler K, Huestis MA. A validated liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometric method for the quantification of methadone, 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP), and 2-ethyl-5-methyl-3,3-diphenylpyroline (EMDP) in human breast milk Journal of Analytical Toxicology. 31: 265-269. PMID 17579970 DOI: 10.1093/jat/31.5.265  0.96
2007 Smith ML, Vorce SP, Holler JM, Shimomura E, Magluilo J, Jacobs AJ, Huestis MA. Modern instrumental methods in forensic toxicology. Journal of Analytical Toxicology. 31: 237-53, 8A-9A. PMID 17579968 DOI: 10.1093/jat/31.5.237  0.36
2007 Jansson LM, Choo RE, Harrow C, Velez M, Schroeder JR, Lowe R, Huestis MA. Concentrations of methadone in breast milk and plasma in the immediate perinatal period. Journal of Human Lactation : Official Journal of International Lactation Consultant Association. 23: 184-90. PMID 17478871 DOI: 10.1177/0890334407300336  0.44
2007 Hahn B, Ross TJ, Yang Y, Kim I, Huestis MA, Stein EA. Nicotine enhances visuospatial attention by deactivating areas of the resting brain default network. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 3477-89. PMID 17392464 DOI: 10.1523/JNEUROSCI.5129-06.2007  0.96
2007 De Martinis BS, Barnes AJ, Scheidweiler KB, Huestis MA. Development and validation of a disk solid phase extraction and gas chromatography-mass spectrometry method for MDMA, MDA, HMMA, HMA, MDEA, methamphetamine and amphetamine in sweat. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 852: 450-8. PMID 17369000 DOI: 10.1016/j.jchromb.2007.02.017  0.96
2007 Huestis MA, Cone EJ. Methamphetamine disposition in oral fluid, plasma, and urine. Annals of the New York Academy of Sciences. 1098: 104-21. PMID 17332086 DOI: 10.1196/annals.1384.038  0.96
2007 Cone EJ, Huestis MA. Interpretation of oral fluid tests for drugs of abuse. Annals of the New York Academy of Sciences. 1098: 51-103. PMID 17332074 DOI: 10.1196/annals.1384.037  0.96
2007 Dams R, Choo RE, Lambert WE, Jones H, Huestis MA. Oral fluid as an alternative matrix to monitor opiate and cocaine use in substance-abuse treatment patients. Drug and Alcohol Dependence. 87: 258-67. PMID 17008030 DOI: 10.1016/j.drugalcdep.2006.08.020  0.96
2007 Huestis MA, Gustafson RA, Moolchan ET, Barnes A, Bourland JA, Sweeney SA, Hayes EF, Carpenter PM, Smith ML. Cannabinoid concentrations in hair from documented cannabis users. Forensic Science International. 169: 129-36. PMID 16963215 DOI: 10.1016/j.forsciint.2006.08.005  0.96
2007 Nikas SP, Thakur GA, Parrish D, Alapafuja SO, Huestis MA, Makriyannis A. A concise methodology for the synthesis of (-)-Δ9-tetrahydrocannabinol and (-)-Δ9-tetrahydrocannabivarin metabolites and their regiospecifically deuterated analogs Tetrahedron. 63: 8112-8123. DOI: 10.1016/j.tet.2007.06.006  0.96
2006 Huestis MA, Smith ML. Modern analytical technologies for the detection of drug abuse and doping. Drug Discovery Today. Technologies. 3: 49-57. PMID 24980101 DOI: 10.1016/j.ddtec.2006.03.004  0.96
2006 Lehrmann E, Colantuoni C, Deep-Soboslay A, Becker KG, Lowe R, Huestis MA, Hyde TM, Kleinman JE, Freed WJ. Transcriptional changes common to human cocaine, cannabis and phencyclidine abuse. Plos One. 1: e114. PMID 17205118 DOI: 10.1371/journal.pone.0000114  0.96
2006 Pirnay SO, Abraham TT, Lowe RH, Huestis MA. Selection and optimization of hydrolysis conditions for the quantification of urinary metabolites of MDMA Journal of Analytical Toxicology. 30: 563-569. PMID 17132253  0.96
2006 Kolbrich EA, Barnes AJ, Gorelick DA, Boyd SJ, Cone EJ, Huestis MA. Major and minor metabolites of cocaine in human plasma following controlled subcutaneous cocaine administration. Journal of Analytical Toxicology. 30: 501-10. PMID 17132243  0.96
2006 Goodwin RS, Gustafson RA, Barnes A, Nebro W, Moolchan ET, Huestis MA. Δ9-tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids Therapeutic Drug Monitoring. 28: 545-551. PMID 16885723 DOI: 10.1097/00007691-200608000-00010  0.96
2006 Huestis MA, Elsohly M, Nebro W, Barnes A, Gustafson RA, Smith ML. Estimating time of last oral ingestion of cannabis from plasma THC and THCCOOH concentrations. Therapeutic Drug Monitoring. 28: 540-4. PMID 16885722 DOI: 10.1097/00007691-200608000-00009  0.96
2006 Copersino ML, Boyd SJ, Tashkin DP, Huestis MA, Heishman SJ, Dermand JC, Simmons MS, Gorelick DA. Quitting among non-treatment-seeking marijuana users: reasons and changes in other substance use. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 15: 297-302. PMID 16867925 DOI: 10.1080/10550490600754341  0.96
2006 Pirnay SO, Abraham TT, Huestis MA. Sensitive gas chromatography-mass spectrometry method for simultaneous measurement of MDEA, MDMA, and metabolites HMA, MDA, and HMMA in human urine Clinical Chemistry. 52: 1728-1734. PMID 16858076 DOI: 10.1373/clinchem.2006.069054  0.96
2006 Schwilke EW, Barnes AJ, Kacinko SL, Cone EJ, Moolchan ET, Huestis MA. Opioid disposition in human sweat after controlled oral codeine administration. Clinical Chemistry. 52: 1539-45. PMID 16740647 DOI: 10.1373/clinchem.2006.067983  0.96
2006 Kim I, Huestis MA. A validated method for the determination of nicotine, cotinine, trans-3'-hydroxycotinine, and norcotinine in human plasma using solid-phase extraction and liquid chromatography-atmospheric pressure chemical ionization-mass spectrometry. Journal of Mass Spectrometry : Jms. 41: 815-21. PMID 16705667 DOI: 10.1002/jms.1039  0.96
2006 Scheidweiler KB, Huestis MA. A validated gas chromatographic-electron impact ionization mass spectrometric method for methylenedioxymethamphetamine (MDMA), methamphetamine and metabolites in oral fluid. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 835: 90-9. PMID 16580268 DOI: 10.1016/j.jchromb.2006.03.020  0.96
2006 Gorelick DA, Heishman SJ, Preston KL, Nelson RA, Moolchan ET, Huestis MA. The cannabinoid CB1 receptor antagonist rimonabant attenuates the hypotensive effect of smoked marijuana in male smokers. American Heart Journal. 151: 754.e1-754.e5. PMID 16504646 DOI: 10.1016/j.ahj.2005.11.006  0.96
2006 Yang W, Barnes AJ, Ripple MG, Fowler DR, Cone EJ, Moolchan ET, Chung H, Huestis MA. Simultaneous quantification of methamphetamine, cocaine, codeine, and metabolites in skin by positive chemical ionization gas chromatography-mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 833: 210-8. PMID 16500159 DOI: 10.1016/j.jchromb.2006.02.002  0.52
2006 Copersino ML, Boyd SJ, Tashkin DP, Huestis MA, Heishman SJ, Dermand JC, Simmons MS, Gorelick DA. Cannabis withdrawal among non-treatment-seeking adult cannabis users. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 15: 8-14. PMID 16449088 DOI: 10.1080/10550490500418997  0.96
2006 Lowe RH, Barnes AJ, Lehrmann E, Freed WJ, Kleinman JE, Hyde TM, Herman MM, Huestis MA. A validated positive chemical ionization GC/MS method for the identification and quantification of amphetamine, opiates, cocaine, and metabolites in human postmortem brain. Journal of Mass Spectrometry : Jms. 41: 175-84. PMID 16382483 DOI: 10.1002/jms.975  0.96
2005 Huestis MA. Pharmacokinetics and metabolism of the plant cannabinoids, Δ9-tetrahydrocannibinol, cannabidiol and cannabinol Handbook of Experimental Pharmacology. 168: 657-690. PMID 16596792 DOI: 10.1007/3-540-26573-2-23  0.96
2005 Kim I, Wtsadik A, Choo RE, Jones HE, Huestis MA. Usefulness of salivary trans-3'-hydroxycotinine concentration and trans-3'-hydroxycotinine/cotinine ratio as biomarkers of cigarette smoke in pregnant women. Journal of Analytical Toxicology. 29: 689-95. PMID 16419402  0.96
2005 Murphy CM, Huestis MA. LC-ESI-MS/MS analysis for the quantification of morphine, codeine, morphine-3-β-D-glucuronide, morphine-6-β-D-glucuronide, and codeine-6-β-D-glucuronide in human urine Journal of Mass Spectrometry. 40: 1412-1416. PMID 16258895 DOI: 10.1002/jms.921  0.96
2005 Huestis MA, Barnes A, Smith ML. Estimating the time of last cannabis use from plasma delta9-tetrahydrocannabinol and 11-nor-9-carboxy-delta9-tetrahydrocannabinol concentrations. Clinical Chemistry. 51: 2289-95. PMID 16223887 DOI: 10.1373/clinchem.2005.056838  0.96
2005 Kacinko SL, Barnes AJ, Schwilke EW, Cone EJ, Moolchan ET, Huestis MA. Disposition of cocaine and its metabolites in human sweat after controlled cocaine administration. Clinical Chemistry. 51: 2085-94. PMID 16166169 DOI: 10.1373/clinchem.2005.054338  0.96
2005 Jones HE, Johnson RE, Jasinski DR, O'Grady KE, Chisholm CA, Choo RE, Crocetti M, Dudas R, Harrow C, Huestis MA, Jansson LM, Lantz M, Lester BM, Milio L. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug and Alcohol Dependence. 79: 1-10. PMID 15943939 DOI: 10.1016/j.drugalcdep.2004.11.013  0.36
2005 Paul BD, Lalani S, Bosy T, Jacobs AJ, Huestis MA. Concentration profiles of cocaine, pyrolytic methyl ecgonidine and thirteen metabolites in human blood and urine: determination by gas chromatography-mass spectrometry. Biomedical Chromatography : Bmc. 19: 677-88. PMID 15841503 DOI: 10.1002/bmc.495  0.96
2005 Boyd SJ, Tashkin DP, Huestis MA, Heishman SJ, Dermand JC, Simmons MS, Gorelick DA. Strategies for quitting among non-treatment-seeking marijuana smokers. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 14: 35-42. PMID 15804875 DOI: 10.1080/10550490590899835  0.96
2005 Moolchan ET, Zimmerman D, Sehnert SS, Zimmerman D, Huestis MA, Epstein DH. Recent marijuana blunt smoking impacts carbon monoxide as a measure of adolescent tobacco abstinence. Substance Use & Misuse. 40: 231-40. PMID 15770886 DOI: 10.1081/JA-200048461  0.96
2005 Scheidweiler KB, Cone EJ, Moolchan ET, Huestis MA. Dose-related distribution of codeine, cocaine, and metabolites into human hair following controlled oral codeine and subcutaneous cocaine administration. The Journal of Pharmacology and Experimental Therapeutics. 313: 909-15. PMID 15743923 DOI: 10.1124/jpet.104.082388  0.96
2005 Choo RE, Murphy CM, Jones HE, Huestis MA. Determination of methadone, 2-ethylidene-1,5-dimethyl-3,3- diphenylpyrrolidine, 2-ethyl-5-methyl-3,3-diphenylpyraline and methadol in meconium by liquid chromatography atmospheric pressure chemical ionization tandem mass spectrometry Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 814: 369-373. PMID 15639461 DOI: 10.1016/j.jchromb.2004.10.068  0.96
2005 Kim I, Darwin WD, Huestis MA. Simultaneous determination of nicotine, cotinine, norcotinine, and trans-3'-hydroxycotinine in human oral fluid using solid phase extraction and gas chromatography-mass spectrometry. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 814: 233-40. PMID 15639444 DOI: 10.1016/j.jchromb.2004.10.034  0.96
2005 Murphy CM, Huestis MA. Liquid chromatographic/electrospray ionization tandem mass spectrometric analysis for the quantification of buprenorphine, norbuprenorphine, buprenorphine-3-β-D-glucuronide and norbuprenorphine-3-β-D-glucuronide in human plasma Journal of Mass Spectrometry. 40: 70-74. PMID 15637731 DOI: 10.1002/jms.776  0.96
2004 Choo RE, Huestis MA. Oral fluid as a diagnostic tool Clinical Chemistry and Laboratory Medicine. 42: 1273-1287. PMID 15576290 DOI: 10.1515/CCLM.2004.248  0.96
2004 Kim I, Oyler JM, Moolchan ET, Cone EJ, Huestis MA. Urinary pharmacokinetics of methamphetamine and its metabolite, amphetamine following controlled oral administration to humans. Therapeutic Drug Monitoring. 26: 664-72. PMID 15570192 DOI: 10.1097/00007691-200412000-00013  0.52
2004 Huestis MA, Cone EJ. Relationship of Δ9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis Journal of Analytical Toxicology. 28: 394-399. PMID 15516285  0.96
2004 Umbricht A, Huestis MA, Cone EJ, Preston KL. Effects of high-dose intravenous buprenorphine in experienced opioid abusers Journal of Clinical Psychopharmacology. 24: 479-487. PMID 15349002 DOI: 10.1097/01.jcp.0000138766.15858.c6  0.96
2004 Choo RE, Huestis MA, Schroeder JR, Shin AS, Jones HE. Neonatal abstinence syndrome in methadone-exposed infants is altered by level of prenatal tobacco exposure. Drug and Alcohol Dependence. 75: 253-60. PMID 15283946 DOI: 10.1016/j.drugalcdep.2004.03.012  0.96
2004 Scheidweiler KB, Huestis MA. Simultaneous quantification of opiates, cocaine, and metabolites in hair by LC-APCI-MS/MS. Analytical Chemistry. 76: 4358-63. PMID 15283573 DOI: 10.1021/ac049555t  0.96
2004 Saito T, Wtsadik A, Scheidweiler KB, Fortner N, Takeichi S, Huestis MA. Validated gas chromatographic-negative ion chemical ionization mass spectrometric method for delta(9)-tetrahydrocannabinol in sweat patches. Clinical Chemistry. 50: 2083-90. PMID 15271860 DOI: 10.1373/clinchem.2004.034868  0.44
2004 Gustafson RA, Kim I, Stout PR, Klette KL, George MP, Moolchan ET, Levine B, Huestis MA. Urinary pharmacokinetics of 11-nor-9-carboxy-delta9-tetrahydrocannabinol after controlled oral delta9-tetrahydrocannabinol administration. Journal of Analytical Toxicology. 28: 160-7. PMID 15107145 DOI: 10.1093/jat/28.3.160  0.96
2004 Kacinko SL, Barnes AJ, Kim I, Moolchan ET, Wilson L, Cooper GA, Reid C, Baldwin D, Hand CW, Huestis MA. Performance characteristics of the Cozart RapiScan Oral Fluid Drug Testing System for opiates in comparison to ELISA and GC/MS following controlled codeine administration. Forensic Science International. 141: 41-8. PMID 15066713 DOI: 10.1016/j.forsciint.2003.12.003  0.96
2003 Gustafson RA, Moolchan ET, Barnes A, Levine B, Huestis MA. Validated method for the simultaneous determination of Δ 9-tetrahydrocannabinol (THC), 11-hydroxy-THC and 11-nor-9-carboxy- THC in human plasma using solid phase extraction and gas chromatography-mass spectrometry with positive chemical ionization Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences. 798: 145-154. PMID 14630369 DOI: 10.1016/j.jchromb.2003.09.022  0.96
2003 Kolbrich EA, Kim I, Barnes AJ, Moolchan ET, Wilson L, Cooper GA, Reid C, Baldwin D, Hand CW, Huestis MA. Cozart RapiScan Oral Fluid Drug Testing System: an evaluation of sensitivity, specificity, and efficiency for cocaine detection compared with ELISA and GC-MS following controlled cocaine administration. Journal of Analytical Toxicology. 27: 407-11. PMID 14606993  0.96
2003 Barnes AJ, Kim I, Schepers R, Moolchan ET, Wilson L, Cooper G, Reid C, Hand C, Huestis MA. Sensitivity, specificity, and efficiency in detecting opiates in oral fluid with the Cozart Opiate Microplate EIA and GC-MS following controlled codeine administration. Journal of Analytical Toxicology. 27: 402-7. PMID 14606992 DOI: 10.1093/jat/27.7.402  0.52
2003 Cone EJ, Sampson-Cone AH, Darwin WD, Huestis MA, Oyler JM. Urine testing for cocaine abuse: Metabolic and excretion patterns following different routes of administration and methods for detection of false-negative results Journal of Analytical Toxicology. 27: 386-401. PMID 14606991  0.96
2003 Dams R, Huestis MA, Lambert WE, Murphy CM. Matrix effect in bio-analysis of illicit drugs with LC-MS/MS: influence of ionization type, sample preparation, and biofluid. Journal of the American Society For Mass Spectrometry. 14: 1290-4. PMID 14597119 DOI: 10.1016/S1044-0305(03)00574-9  0.96
2003 Preston KL, Epstein DH, Davoudzadeh D, Huestis MA. Methadone and metabolite urine concentrations in patients maintained on methadone Journal of Analytical Toxicology. 27: 332-341. PMID 14516485  0.96
2003 Kim I, Barnes AJ, Schepers R, Moolchan ET, Wilson L, Cooper G, Reid C, Hand C, Huestis MA. Sensitivity and specificity of the Cozart microplate EIA cocaine oral fluid at proposed screening and confirmation cutoffs. Clinical Chemistry. 49: 1498-503. PMID 12928231 DOI: 10.1373/49.9.1498  0.52
2003 Dams R, Murphy CM, Lambert WE, Huestis MA. Urine drug testing for opioids, cocaine, and metabolites by direct injection liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry : Rcm. 17: 1665-70. PMID 12845594 DOI: 10.1002/rcm.1098  0.96
2003 Gustafson RA, Levine B, Stout PR, Klette KL, George MP, Moolchan ET, Huestis MA. Urinary cannabinoid detection times after controlled oral administration of delta9-tetrahydrocannabinol to humans. Clinical Chemistry. 49: 1114-24. PMID 12816908 DOI: 10.1373/49.7.1114  0.96
2003 Pope HG, Gruber AJ, Hudson JI, Cohane G, Huestis MA, Yurgelun-Todd D. Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug and Alcohol Dependence. 69: 303-10. PMID 12633916 DOI: 10.1016/S0376-8716(02)00334-4  0.96
2003 Lehrmann E, Oyler J, Vawter MP, Hyde TM, Kolachana B, Kleinman JE, Huestis MA, Becker KG, Freed WJ. Transcriptional profiling in the human prefrontal cortex: evidence for two activational states associated with cocaine abuse. The Pharmacogenomics Journal. 3: 27-40. PMID 12629581 DOI: 10.1038/sj.tpj.6500146  0.96
2003 Dams R, Murphy CM, Choo RE, Lambert WE, De Leenheer AP, Huestis MA. LC-atmospheric pressure chemical ionization-MS/ MS analysis of multiple illicit drugs, methadone, and their metabolites in oral fluid following protein precipitation. Analytical Chemistry. 75: 798-804. PMID 12622369 DOI: 10.1021/ac026111t  0.96
2003 Schepers RJ, Oyler JM, Joseph RE, Cone EJ, Moolchan ET, Huestis MA. Methamphetamine and amphetamine pharmacokinetics in oral fluid and plasma after controlled oral methamphetamine administration to human volunteers. Clinical Chemistry. 49: 121-32. PMID 12507968 DOI: 10.1373/49.1.121  0.96
2002 Steckley SL, Darwin WD, Henningfield JE, Huestis MA, Pickworth WB. Eclipse can deliver crack cocaine. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 4: S189-90. PMID 12573180 DOI: 10.1080/1462220021000032807  0.96
2002 Preston KL, Epstein DH, Cone EJ, Wtsadik AT, Huestis MA, Moolchan ET. Urinary elimination of cocaine metabolites in chronic cocaine users during cessation Journal of Analytical Toxicology. 26: 393-400. PMID 12422991 DOI: 10.1093/jat/26.7.393  0.96
2002 Pope HG, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D. Cognitive measures in long-term cannabis users. Journal of Clinical Pharmacology. 42: 41S-47S. PMID 12412835  0.96
2002 Oyler JM, Cone EJ, Joseph RE, Moolchan ET, Huestis MA. Duration of detectable methamphetamine and amphetamine excretion in urine after controlled oral administration of methamphetamine to humans. Clinical Chemistry. 48: 1703-14. PMID 12324487  0.96
2002 LeBeau MA, Christenson RH, Levine B, Darwin WD, Huestis MA. Intra- and interindividual variations in urinary concentrations of endogenous gamma-hydroxybutyrate. Journal of Analytical Toxicology. 26: 340-6. PMID 12220015  0.96
2002 Huestis MA, Choo RE. Drug abuse's smallest victims: In utero drug exposure Forensic Science International. 128: 20-30. PMID 12208017 DOI: 10.1016/S0379-0738(02)00160-3  0.96
2002 Murphy CM, Dams R, ElSohly MA, Huestis MA. Quantitative determination of buprenorphine, norbuprenorphine, buprenorphine-glucuronide, and norbuprenorphine-glucuronide in human plasma by protein precipitation LC-MS/MS Proceedings 50th Asms Conference On Mass Spectrometry and Allied Topics. 551-552.  0.96
2002 Dams R, Murphy CM, Choo RE, Lambert WE, Huestis MA. Development of a rugged and sensitive LC-APCI-MS/MS method combined with simplified sample preparation for the comprehensive analysis of drugs of abuse in biological fluids Proceedings 50th Asms Conference On Mass Spectrometry and Allied Topics. 677-678.  0.96
2001 Spanbauer AC, Casseday S, Davoudzadeh D, Preston KL, Huestis MA. Detection of opiate use in a methadone maintenance treatment population with the CEDIA® 6-acetylmorphine and CEDIA DAU opiate assays Journal of Analytical Toxicology. 25: 515-519. PMID 11599593  0.96
2001 Pope HG, Gruber AJ, Hudson JI, Huestis MA, Yurgelun-Todd D. Neuropsychological performance in long-term cannabis users. Archives of General Psychiatry. 58: 909-15. PMID 11576028  0.96
2001 Polettini A, Huestis MA. Simultaneous determination of buprenorphine, norbuprenorphine, and buprenorphine-glucuronide in plasma by liquid chromatography-tandem mass spectrometry Journal of Chromatography B: Biomedical Sciences and Applications. 754: 447-459. PMID 11339288 DOI: 10.1016/S0378-4347(01)00029-9  0.96
2001 Huestis MA, Gorelick DA, Heishman SJ, Preston KL, Nelson RA, Moolchan ET, Frank RA. Blockade of effects of smoked marijuana by the CB1-selective cannabinoid receptor antagonist SR141716. Archives of General Psychiatry. 58: 322-8. PMID 11296091 DOI: 10.1001/archpsyc.58.4.322  0.96
2001 Woods AS, Huestis MA. A study of peptide--peptide interaction by matrix-assisted laser desorption/ionization. Journal of the American Society For Mass Spectrometry. 12: 88-96. PMID 11142364 DOI: 10.1016/S1044-0305(00)00197-5  0.96
2001 Preston KL, Umbricht A, Huestis MA, Cone EJ. Intravenous buprenorphine: Effects of 2 to 16 mg doses in nondependent opioid abusers Clinical Pharmacology and Therapeutics. 69.  0.96
2000 Ladenheim B, Krasnova IN, Deng X, Oyler JM, Polettini A, Moran TH, Huestis MA, Cadet JL. Methamphetamine-induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6. Molecular Pharmacology. 58: 1247-56. PMID 11093760 DOI: 10.1124/mol.58.6.1247  0.96
2000 Oyler JM, Cone EJ, Joseph RE, Huestis MA. Identification of hydrocodone in human urine following controlled codeine administration. Journal of Analytical Toxicology. 24: 530-5. PMID 11043655  0.96
2000 Huestis MA, Cone EJ, Wong CJ, Umbricht A, Preston KL. Monitoring opiate use in substance abuse treatment patients with sweat and urine drug testing Journal of Analytical Toxicology. 24: 509-521. PMID 11043653  0.96
2000 Moolchan ET, Cone EJ, Wstadik A, Huestis MA, Preston KL. Cocaine and metabolite elimination patterns in chronic cocaine users during cessation: Plasma and saliva analysis Journal of Analytical Toxicology. 24: 458-466. PMID 11043647  0.96
1999 Huestis MA, Oyler JM, Cone EJ, Wstadik AT, Schoendorfer D, Joseph RE. Sweat testing for cocaine, codeine and metabolites by gas chromatography-mass spectrometry. Journal of Chromatography. B, Biomedical Sciences and Applications. 733: 247-64. PMID 10572984 DOI: 10.1016/S0378-4347(99)00246-7  0.96
1999 Nath N, Eldefrawi M, Wright J, Darwin D, Huestis M. A rapid reusable fiber optic biosensor for detecting cocaine metabolites in urine. Journal of Analytical Toxicology. 23: 460-7. PMID 10517551  0.96
1999 Preston KL, Huestis MA, Wong CJ, Umbricht A, Goldberger BA, Cone EJ. Monitoring cocaine use in substance-abuse-treatment patients by sweat and urine testing Journal of Analytical Toxicology. 23: 313-322. PMID 10488917 DOI: 10.1093/jat/23.5.313  0.96
1999 Preston KL, Huestis MA, Wong CJ, Cone EJ. Urine and sweat monitoring of illicit opiate use Clinical Pharmacology and Therapeutics. 65: 153.  0.96
1998 Huestis MA, Cone EJ. Differentiating new marijuana use from residual drug excretion in occasional marijuana users Journal of Analytical Toxicology. 22: 445-454. PMID 9788519  0.96
1998 Huestis MA, Cone EJ. Urinary excretion half-life of 11-nor-9-carboxy-Δ9- tetrahydrocannabinol in humans Therapeutic Drug Monitoring. 20: 570-576. PMID 9780137 DOI: 10.1097/00007691-199810000-00021  0.96
1996 Huestis MA, Mitchell JM, Cone EJ. Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana. Journal of Analytical Toxicology. 20: 441-52. PMID 8889681  0.96
1996 Huestis MA. Judicial acceptance of hair tests for substances of abuse in the United States courts: Scientific, forensic, and ethical aspects Therapeutic Drug Monitoring. 18: 456-459. PMID 8857568 DOI: 10.1097/00007691-199608000-00025  0.96
1995 Huestis MA, Mitchell JM, Cone EJ. Detection times of marijuana metabolites in urine by immunoassay and GC-MS. Journal of Analytical Toxicology. 19: 443-9. PMID 8926739 DOI: 10.1093/jat/19.6.443  0.96
1995 Jenkins AJ, Darwin WD, Huestis MA, Cone EJ, Mitchell JM. Validity testing of the accuPINCH THC test. Journal of Analytical Toxicology. 19: 5-12. PMID 7723303 DOI: 10.1093/jat/19.1.5  0.96
1994 Huestis MA, Mitchell JM, Cone EJ. Lowering the federally mandated cannabinoid immunoassay cutoff increases true-positive results. Clinical Chemistry. 40: 729-33. PMID 8174244  0.96
1993 Cone EJ, Huestis MA, Mitchell JM. Do consecutive urine catches differ in marijuana metabolite concentration? Journal of Analytical Toxicology. 17: 186-7. PMID 8336494 DOI: 10.1093/jat/17.3.186  0.96
1993 Huestis MA, Cone EJ. Relating blood concentrations of tetrahydrocannabinol and metabolites to pharmacologic effects and time of marijuana usage Therapeutic Drug Monitoring. 15: 527-532. PMID 8122288  0.96
1993 Jenkins AJ, Mills LC, Darwin WD, Huestis MA, Cone EJ, Mitchell JM. Validity testing of the EZ-SCREEN cannabinoid test. Journal of Analytical Toxicology. 17: 292-8. PMID 8107464 DOI: 10.1093/jat/17.5.292  0.96
1993 Huestis MA, Cone EJ. Concerning Blood Cannabinoids and the Effect of Residual THCCOOH on Calculated Exposure Time: Reply Journal of Analytical Toxicology. 17: 314-316. DOI: 10.1093/jat/17.5.314  0.52
1992 Huestis MA, Henningfield JE, Cone EJ. Blood cannabinoids. ii. models for the prediction of time of marijuana exposure from plasma concentrations of ∆9-tetrahydrocannabinol (thc)and 11-nor-9-carboxy-∆9- tetrahydrocannabinol (thccooh) Journal of Analytical Toxicology. 16: 283-290. PMID 1338216 DOI: 10.1093/jat/16.5.283  0.96
1992 Huestis MA, Henningfield JE, Cone EJ. Blood cannabinoids. i. absorption of thc and formation of 11-oh-thc and thccooh during and after smoking marijuana Journal of Analytical Toxicology. 16: 276-282. PMID 1338215 DOI: 10.1093/jat/16.5.276  0.96
1992 Huestis MA, Sampson AH, Holicky BJ, Henningfield JE, Cone EJ. Characterization of the absorption phase of marijuana smoking Clinical Pharmacology and Therapeutics. 52: 31-41. PMID 1320536  0.96
1990 Heishman SJ, Huestis MA, Henningfield JE, Cone EJ. Acute and residual effects of marijuana: profiles of plasma THC levels, physiological, subjective, and performance measures. Pharmacology, Biochemistry, and Behavior. 37: 561-5. PMID 1965045 DOI: 10.1016/0091-3057(90)90028-G  0.96
Show low-probability matches.